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Abstract  
DNA damage is extremely detrimental to the cell and must be repaired to protect 
the genome. A variety of mechanisms exist to repair DNA damage, which speaks to the 
importance of the integrity of DNA.  DNA is capable of conducting charge through the 
overlapping π-orbitals of stacked bases; this phenomenon is extremely sensitive to 
perturbations in the π-stack, as they attenuate DNA charge transport (CT). Based on the 
E. coli base excision repair (BER) proteins EndoIII and MutY, it has recently been 
proposed that redox-active proteins containing metal clusters can utilize DNA CT to 
signal one another to locate sites of DNA damage.   
 To expand our repertoire of proteins capable of utilizing DNA-mediated 
signaling, we measured the DNA-bound redox potential of the nucleotide excision repair 
(NER) helicase XPD from Sulfolobus acidocaldarius.  A midpoint potential of 82 mV 
versus NHE was observed, resembling that of the previously reported BER proteins.  The 
redox signal increases in intensity with ATP hydrolysis in only the WT protein and 
mutants that maintain ATPase activity; an increase was not observed for ATPase-
deficient mutants.   The signal increase was found to correlate directly with ATP activity, 
suggesting that DNA-mediated signaling may play a general role in protein signaling.   
   Several mutations in human XPD that lead to XP-related diseases have been 
identified.  Using SaXPD, we explored how these mutations, which are conserved in the 
thermophile, affect protein electrochemistry.  Biochemically, the G34R, R460P, and 
A511R mutants are both ATPase- and helicase-deficient, while the L325V and R460W 
mutants have activities resembling the WT protein.  On DNA-modified electrodes, the 
G34R mutant exhibits a redox signal comparable to the WT protein, while the L325V, 
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R460P, R460W and A511R mutants are CT deficient.  Attempts were made to restore CT 
activity to CT-deficient mutants using an artificial mutant, Y104A, that showed an 
enhanced redox signal.  However, incorporation of this second Y104A mutation into CT-
deficient mutants did not restore their CT capabilities.  Based on the SaXPD crystal 
structure, we also modeled an L325V/M331A mutant in another attempt to restore CT, 
which was similarly unsuccessful. 
To further understand the electrochemical signaling of XPD, we initiated studies 
on the yeast S. cerevisiae Rad3 protein.  After purification, we measured ATPase, 
helicase, and DNA-binding activities of the WT, G47R, I463V/del716-730, R618P, 
R618W, and C665R protein mutants, which are analagous mutations to those explored in 
SaXPD.  The Rad3 protein exhibits activity similar to the SaXPD proteins.  Interestingly, 
the Rad3 mutants all contain a [4Fe-4S] cluster, as evidenced by a UV-Vis absorbance at 
410 nm.  ScRad3 mutants were incubated on a DNA-modified electrode, and exhibit a 
midpoint redox potential of 80 mV versus NHE consistent with the previously reported 
proteins containing [4Fe-4S] clusters. 
 To investigate the role of Rad3 in vivo, we developed a haploid strain of S. 
cerevisiae that has Rad3 knocked out and complemented with Rad3 on a plasmid.  In 
both a UV-and a 4-nitroquinoline 1-oxide (NQO) survival assay, the ATPase- and 
helicase-deficient G47R, R618P, and C665R mutants have little to no survival at either 
20 J/m2 or 20 ng/mL NQO, while the mutants I463V/del716-730 and R618W exhibit 
survival similar to WT.  Growth curves show similar results; ATPase and helicase 
deficient mutants show t1/2 shifts greater than 15 hours compared to the WT strain, which 
has a t1/2 shift of only 1.5 hours.  When assayed on DNA-modified electrodes, these 
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protein mutants exhibit DNA signals closely resembling the WT protein, suggesting these 
mutations do not alter the potential of the cluster.  Finally, the survival ability of these 
strains in the presence of different DNA damaging agents was tested. When the WT and 
G47R strains were challenged with hydroxyurea (HU), methyl methanesulfonate (MMS), 
and camptothecin (CPT), both strains exhibit comparable activity in the presence of HU, 
while with MMS and CPT, the G47R strain exhibits a significant change in t1/2 compared 
to the WT, suggesting that Rad3 is involved in repairing damage beyond traditional NER 
substrates.   
 We additionally utilized an atomic force microscopy (AFM) assay that measures 
the ability of proteins to relocalize in the vicinity of damage.  In protein samples of 
EndoIII or SaXPD, we observed a binding density ratio (BDR) of ~1.5 for both proteins, 
suggesting that the proteins redistribute onto the strands containing a single C:A 
mismatch.  However, in mixtures of protein samples where either EndoIII or SaXPD is 
CT-deficient, a BDR of ~1.0 is observed.  These data suggest that a) proteins from 
completely different repair pathways and organisms can signal one another to coordinate 
to a site of DNA damage and b) that deficiencies in CT play a large role in coordinating 
protein binding at sites of DNA damage. 
 The results described here involve investigations of new proteins for DNA repair 
that contain a redox active [4Fe-4S] cluster.  By utilizing electrochemistry, an AFM 
assay, and previously established spectroscopic techniques, we have characterized a new 
group of proteins capable of performing DNA-mediated CT.   We find that protein 
activity can be correlated to electrochemical activity, and that DNA-mediated signaling 
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can be utilized by a variety of DNA repair proteins that bind DNA and contain a [4Fe-4S] 
cluster. 
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DNA repair and DNA charge transport 
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DNA Repair Pathways 
DNA is constantly assaulted by a variety of damage sources, ranging from 
endogenous reactive oxygen species and chemical damaging agents to external high 
energy UV light (1, 2). Each of these agents causes damage that, if unrepaired, leads to 
extended genomes, mutations, and cell death.  Cells have a variety of DNA repair 
pathways for specific types of damage, such as base excision repair (BER), which 
involves the excision of a single damaged base, followed by gap filling and ligation by a 
polymerase (3). Nucleotide excision repair (NER), in contrast, involves larger substrates 
that distort the structure of DNA and are repaired by an entirely different family of 
enzymes (4, 5). Mismatch repair (MMR) machinery uniquely repairs mismatches that 
occur through DNA polymerization errors (2). While each pathway is almost entirely 
independent, some enzymatic overlap exists; for example, DNA polymerase ε is utilized 
in both NER and BER. Although the activity of each of the proteins in these pathways is 
understood, it is not known how proteins from each pathway target their specific lesions 
(6).  In cells, these repair pathways work in tandem to repair the genome before 
mutations are passed on to future generations. 
Base Excision Repair 
 Base excision repair (BER), a well conserved pathway found in both bacteria and 
eukaryotes, handles the removal of a damaged base.  The enzymes that perform this 
excision are known as glycosylases because they excise the base from the sugar.   DNA 
bases have many reactive groups, including carbonyls and amines, that can readily react 
with various chemicals (3).  For example, cytosine is easily deaminated to form uracil, 
which must be subsequently removed by uracil deglycosylase, and guanine can be 
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oxidized to 8-oxo-guanine, which is removed by the MutY family of DNA glyscosylases.  
These are just a few examples of a slew of other base damage products that have specific 
glycosylases ready to repair them.  
Guanine is particularly susceptible to damage as it has the lowest oxidation 
potential of all the bases, and is therefore especially prone to oxidation by reactive 
oxygen species (ROS), which are often indicators of oxidative stress in a cell.  The most 
common oxidation product is 7,8-dihydro-8-oxoguanine (8-oxoguanine, Figure 1.1), 
which is extremely deleterious to the cell because 8-oxoguanine can behave like a 
thymine.  During replication, this oxidized base can lead to an 8-oxoG:A base pair 
instead of the correct G:C base pair, and a subsequent round of replication will lead to a 
T:A transversion (Figure 1.1).  The cell has evolved enzymes capable of repairing this 
damage prior to the incorrect T:A insertion.  Initially, MutM (OGG1) excises 8-oxoG 
from the 8-oxoG:C base pair, but if this lesion remains unrepaired, MutY (MUTYH) 
remove adenines from the 8:oxoG:A base pair.  Once the damaged or incorrect bases are 
removed, polymerases can complete DNA synthesis without transversion (3).  Mutations 
in the human MutY protein have been directly linked to colorectal cancer; when missense 
mutations are present in MutY, polyps are often found in the colon, known as MUTYH-
associated polyposis.  A variety of other progeria exist as a result of BER deficiences, but 
the MutY system is the best characterized.   
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Figure 1.1.  Base excision repair schematic.  (A).  Chemical structures of an 8-oxo 
guanine: cytosine base pair and an 8-oxo guanine: adenine base pair.  (B).  Repair process 
by which DNA is oxidized by a reactive oxygen species (ROS) to generate an 8-oxo 
guanine: cytosine mis-pair.  This can either be removed by OGG1 and subsequently 
repaired, or a replication error inducing an 8-oxo guanine : adenine mis pair occurs.  In 
this case, MutY must repair the lesion, or a T : A transversion will be permanently 
included into the DNA genome. 
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Mismatch Repair 
 Mismatches in DNA occur when bases pair in a non-Watson Crick fashion 
(adenine always pairs with thymine and guanine with cytosine).  Mismatches are not 
typically chemically induced, but are the byproducts of poor polymerization (7).  In the 
cell, DNA is replicated at thousands of base pairs per second by the leading strand DNA 
polymerase ε and the lagging strand DNA polymerases α and δ.  These proteins replicate 
DNA at staggering speeds, but are especially error prone.  To combat these errors, they 
contain a proofreading function to verify that the correct nucleotides were incorporated, 
but errors still occur at a rate of 1 per 1000’s of base pairs synthesized (8). Errors are 
corrected through the mismatch repair (MMR) pathway, which is conserved between 
bacteria and eukaryotes.  MMR is a constant search and repair process generally broken 
down into four steps.  The first is recognition of the mismatch site, performed by the 
MutS family of proteins.  In humans, a heterodimer termed MutSα, composed of human 
MSH2 and human MSH6, identifies base pair mismatches, while the MutSβ complex, 
composed of human MSH2 and MSH3, scans for insertion and deletion loops.  Based on 
crystal structures, it is currently believed that the complex binds DNA at mismatch sites 
and actively scans as a sliding clamp with a higher affinity for mismatch DNA in the 
ATP-bound form and a lower affinity in the ADP-bound form (9) (Figure 1.2). 
 Subsequent steps in MMR involve the recruitment of additional repair enzymes.  
In humans, the DNA-MutS-ATP complex brings in the MutL complex, which displaces 
DNA polymerases and PCNA while also recruiting exonuclease I (Exo1).  The nuclease 
then cleaves either upstream or downstream of the mismatch, which leaves an exposed 
ssDNA region.  This is bound by PCNA, RFCs, and other polymerases.    Finally, DNA 
is resynthesized by DNA polymerase δ to complete the repair process (2) (Figure 1.2).  
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MMR proteins are therefore very important, and mutations in MMR predispose patients 
to certain types of cancers as well as Lynch syndrome (9).  
 7 
 
Figure 1.2.  Mismatch repair cartoon schematic.  Briefly, the MutSα (blue and green 
ring) binds to a mismatch site upon ATP hydrolysis.  The complex slides along the DNA 
and recruits an exonuclease such as Exonuclease I (ExoI), which then degrades one 
strand of the DNA, allowing for the PCNA/RFC/polymerase complex to bind and 
polymerize DNA.  This leads to reversion of the DNA mismatch from A : C to G : C. 
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Double Strand Break Repair 
 Double strand breaks (DSBs) are extremely detrimental to the cell, as they make 
DNA more susceptible to a large-scale deletion or other damage that can result in cell 
death.  Double strand breaks are typically caused by collapsed replication forks, 
nucleases, or exogenous ionizing radiation (10). A double strand break is far more 
dangerous than a single strand break because there is ambiguity as to which strand is the 
parent strand, making repair significantly more difficult.  The two principal methods for 
repairing DSBs are either non-homologous end joining (NHEJ) or homologous 
recombination (HR).  NHEJ is considered to be more error-prone, as the termini are 
rejoined through ligation, while in HR an exchange of two DNA strands occurs, which 
generally is thought to be error-free (11) (Figure 1.3).    
Non-homologous End Joining Repair 
 A major challenge associated with repairing a double strand break is that the 
damage can be induced by a variety of sources. Additionally, DSBs typically do not have 
a clean 5ʹ′ phosphate and 3ʹ′ hydroxyl, which are necessary for ligation.  Unlike HR, which 
aligns DNA based on sequence homology, NHEJ ligates the DNA quickly and 
efficiently.  Because this process is independent of sequence, NHEJ is thought to be the 
primary repair mechanism in non S-phase cells, which have sister chromatids in close 
proximity, allowing for easy HR.  In NHEJ, following break formation the termini are 
bound with the Ku70/80 heterodimer, which recruits the DNA protein kinase catalytic 
subunit (XRCC4, XLF and DNA ligase IV).  If no end processing is required and the 
DNA can be ligated, the ligase completes the repair (10). However, more often the DNA 
must be processed to provide the reactive groups required for ligation.  If further 
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processing is required, other proteins, including Artemis, are recruited to cleave the ends 
of the DSB complex to generate a viable overhang for ligation by either polymerase  µ or 
polymerase  λ  (Figure 1.3).  NHEJ is important for efficient repair of DSBs and is one of 
many pathways required to maintain genome integrity.   
Homologous Recombination  
 HR is vital for introducing genetic variability and maintaining genome stability.  
This process is more complicated and not as well understood as NHEJ, as it involves 
coordinated repair between two DNA strands.  Briefly, when a strand break is generated, 
the broken end is base paired with the correct complement in the sister chromatid by a 
recombinase-coated single stranded DNA.  Upon sequence alignment, recombinases 
switch homologous regions, allowing DNA polymerization to occur from the newly 
formed D-loop.  A branch is then created that migrates and resolves to form intact DNA 
with few errors present (12). This process is much more common in S-phase when both 
sister chromatids are in close proximity.  HR is a vital process for the prevention of DNA 
damage and requires a variety of proteins for both alignment and repair of the DSB. 
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Figure 1.3.  DSB repair by NHEJ.  Repair via non-homologous end joining (NHEJ).  A 
DSB is formed and bound by the Ku70/80 heterodimer (blue/green balls), and, if end 
resection is necessary, the proteins recruit Artemis and other proteins to resect the ends.  
However, if the ends are capable of direct ligation, ligases are recruited for direct 
ligation. 
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Nucleotide Excision Repair 
 NER is responsible for repairing a variety of bulky DNA lesions including UV-
induced cyclopyrimidine dimers and chemically-induced DNA damage.  These DNA 
lesions are larger than BER or MMR damage sites and often lead to replication errors and 
mutations not typically found in those pathways (6). Many proteins involved in NER are 
implicated in xeroderma pigmentosum (XP)-related diseases, which impart 
photosensitivity, growth deficiencies, predisposition to cancer, and other aging 
phenotypes (13). Over thirteen individual proteins have been implicated in the three main 
NER disorders: xeroderma pigmentosum (XP), trichothiodystrophy (TTD), or cockayne 
syndrome (CS) (14).  Two types of NER exist: global genome repair (GGR) and 
transcription-coupled repair (TCR).  When damage occurs over a transcribed region, 
repair is coordinated with transcription; the polymerase pauses near a site of damage and 
recruits the CSA and CSB proteins.  The TFIIH core complex, which consists of ten 
protein subunits including the helicases XPD and XPB, is then recruited.  These helicases 
unwind the DNA near the site of damage to expose it to recruited excision proteins, XPF 
and XPG. These proteins complete the process through backbone cleavage upstream and 
downstream of the lesion.  Following excision, PCNA-polymerase completes synthesis, 
and the newly synthesized DNA is ligated.  In global genome repair, an alternate 
recognition element is utilized: XPE or XPC protein is brought to the site of DNA 
damage.  Upon binding, these proteins recruit the TFIIH complex, as described above, 
and complete NER similarly to TCR (15) (Figure 1.4).   
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Figure 1.4.  Nucleotide excision repair schematic.  (A) Chemical structure of two 
proximal thymines forming a thymine dimer.  (B).  Cartoon schematic of global genome 
repair (GGR), in which XPC first binds the site of DNA damage, followed by recruitment 
of XPD and TFIIH (which is composed of 10-subunits including XPB and XPD).  These 
helicases then unwind around the site of the lesion and recruit XPF and XPG, which 
cleave on the 5ʹ′ and 3ʹ′ sides of the lesion respectively.  This cut DNA is then removed, 
and polymeraes and ligases complete the repair process.  In transcription coupled repair 
(TCR), RNA polymerase stalls near the site of the lesion and recruits CSA and CSB 
proteins, which then follow the normal GGR pathway as indicated by the arrow. 
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DNA-mediated Charge Transport 
 DNA is composed of a sequence of four different nucleobases connected by a 
sugar phosphate backbone.  The DNA deoxyribose bases hydrogen bond between strands 
to form basepairs.  The anti-parallel annealing of DNA strands causes base stacking, 
which aligns the π-orbitals of the bases, enabling electrons to pass through the 
overlapping π-orbitals (Figure 1.5).  This phenomenon, known as DNA Charge Transport 
(CT), enables DNA to act as a molecular wire (16). Structurally, this process is 
unaffected by breaks in the sugar phosphate backbone (17). However, perturbations to the 
DNA π-stack significantly diminish its ability to conduct charge; in DNA, oxidized bases 
(8-oxo-guanine) and mismatches (cytosine-adenine mismatch) disrupt the π-stacking and 
interfere with CT (18) (Figure 1.5). Using a chemical probe, DNA CT has been measured 
by our group through 100 bases.  DNA CT over this distance opens the possibility that 
this process occurs in the cell (19). 
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Figure 1.5 DNA charge transport (Top Left) Side-on view of DNA with sugar 
phosphate backbone shown in orange and the individual bases from (PDB ID 1BNA).  
(Top Right)  Top view of DNA showing that the bases are stacked upon one another, 
allowing for efficient charge transfer (from PDB ID 1BNA).  (A) Side-view and Top-
view of single electrodes utilized in the Barton laboratory showing the reference 
(Ag/AgCl), auxillary (platinum wire) and working surface (DNA self-assembled 
monolayer on gold).  (B) Chemical structures of the cystosine (C): adenine (A) mismatch 
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and the guanine (G) : thymine (T) mismatch.  (C) Electrochemical signal on a DNA self-
assembled monolayer (SAM) using well-matched (WT) and mismatched (MM) DNA 
showing the attenuation of CT by a single DNA mismatch or lesion.
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Redox signaling in the cell 
 Cells contain many redox active molecules that are used to control the redox 
potential of the cell, including those capable of reacting with and modifying proteins. 
Some molecules include hydrogen peroxide, peroxynitrite, and nitrogen dioxide.  Thiol-
based switches utilize redox chemistry to convert two free thiols (from cysteines and 
methionines) into a disulfide.  This is a two-electron process that creates a simple and 
reliable switch for proteins based on redox conditions of a cell.  The redox potential in 
bacteria is approximately -165 mV in the periplasm, making the reduction/oxidation of 
disulfides easy (20). The formation of disulfides is also interesting because the 
conformation of the protein can change upon bond formation, which affects the catalytic 
ability of the protein.  When a disulfide is formed, the protein is locked into a new state 
that can bind or block substrate binding.  This redox control is relatively simple, yet 
provides an impetus to study these proteins as redox switches. 
Many proteins contain redox active moieties.  Redox potentials have been 
measured from -320 mV to upwards of 115 mV, all of which are achievable in the cell.  
One molecule used to measure the redox potential is glutathione; the ratio of GSH/GSSG 
gives a good representation of the redox environment of the cell.  The ratio is typically 
200:1, but under conditions of oxidative stress and other situations that affect the redox 
potential of the cell, the ratio can change significantly (21). Many molecules have also 
been implicated in controlling the redox state of the cell, which also affects the proteins 
therein through chemical reactions with free radicals and other ROS (22). Under 
conditions of oxidative stress, activation of the Dsb proteins have been shown to be 
controlled by this redox chemistry.  The versatility of the disulfide bond provides an 
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excellent mechanism for cellular signaling via redox chemistry through intracellular 
reductants and oxidants. 
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Activation of transcription via DNA CT 
 DNA-mediated CT provides an alternative means of redox signaling between 
proteins.  As opposed to using disulfides for redox chemistry, the transcription factor 
SoxR contains a [2Fe-2S] cluster, which provides an alternative method of redox 
chemistry.  SoxR was originally identified because of its transcriptional activity in 
response to oxidative stress; when bound to DNA, it exhibits a redox potential of 
approximately 200 mV versus NHE, compared to the unbound redox potential of -300 
mV (23). Interestingly, absence of the cluster in SoxR does not affect binding affinity or 
folding, but when oxidized, SoxS transcription is induced.  Using a covalent rhodium 
photooxidant, researchers were able to demonstrate that SoxS transcription can be 
induced via DNA CT and not simply via oxidation of the cysteines in the protein, 
suggesting a transcriptional role for DNA-mediated signaling (24).   
Cellular processes involving DNA CT  
 DNA-mediated signaling has yet to be concretely proven to be utilized in the cell, 
but many nucleic acid structures in the cell are capable of conducting charge.  DNA 
wrapped in a histone core particle was shown to be oxidized by photooxidation of a 
rhodium metal complex, damaging the 5ʹ′-guanines in a guanine doublet (25). DNA 
damage has also been observed in HeLa cell nuclei using a similar photooxidation 
strategy, demonstrating again that the low potential guanine doublet is a preferred site for 
DNA damage (26). If DNA is capable of conducting charge through these biologically 
relevant structures, it provides a potentially unique pathway for protein signaling.  
Bending of DNA by the TATA binding protein, which attenuates CT, has also been 
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observed (27). Both SoxR signaling and TBP signal attenuation present unique 
opportunities for proteins to regulate DNA CT.   
 20 
DNA CT through metalloproteins 
 Proteins have a variety of co-factors, ranging from organic chromophores to 
metals such as zinc and iron.  Recently, it has been proposed that DNA CT may be 
utilized in vivo by proteins containing redox active moieties based on experiments with 
the BER proteins Endonuclease III (EndoIII) and MutY, both of which contain a redox 
active [4Fe-4S] cluster (28).  DNA binding shifts the reduction potential of these clusters 
by approximately -200 mV to 80 mV vs. NHE.  Additionally, in the oxidized state (3+) 
these proteins have a 1000-fold higher DNA binding affinity than in their reduced state 
(2+) (29, 30).  An AFM assay confirmed that these proteins redistribute onto strands that 
contain a single base mismatch, which reduces the ability for the proteins to communicate 
via DNA CT (31). These findings point to a DNA-mediated CT model for protein 
localization near sites of DNA damage.  In this model, freely-diffusing proteins bind 
DNA, activating them towards oxidation and subsequent release of an electron that 
travels through the DNA to a distally-bound protein.  This distal protein is reduced by the 
electron and dissociates from the DNA; these proteins essentially conduct a scan of this 
region of the genome (Figure 1.6).  However, if the proteins cannot communicate due to 
perturbations to the π-stack, the distal protein will not dissociate and will instead localize 
in the region of damage (32).  An E. coli assay measuring MutY activity demonstrated 
that a CT deficient mutant of EndoIII decreases the efficiency of the MutY enzyme in 
repairing lesions (28). It was subsequently determined that with only MutY and EndoIII 
proteins, it would take an E. coli cell over 40 minutes to scan the entire genome, much 
longer than the doubling time of the cell.  However, if DNA CT occurs over only several 
hundred base pairs, the search time is reduced from 40 minutes to 5 minutes (28). While 
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these proteins are both involved in BER, they act on completely different substrates; our 
findings therefore indicate that there must be cross-communication between these 
proteins, perhaps by DNA-mediated Charge Transfer.    
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Figure 1.6 Proposed model for DNA-mediated signaling. Proposed model for DNA-
mediated signaling between [4Fe-4S] cluster containing proteins. 
 23 
References 
1. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K., and Linn, S. (2004) 
Molecular mechanisms of mammalian DNA repair and the DNA damage 
checkpoints, Annu Rev Biochem 73, 39-85. 
2. Kunkel, T. A., and Erie, D. A. (2005) DNA mismatch repair, Annu Rev Biochem 
74, 681-710. 
3. David, S. S., O'Shea, V. L., and Kundu, S. (2007) Base-excision repair of 
oxidative DNA damage, Nature 447, 941-950. 
4. de Boer, J., and Hoeijmakers, J. H. (2000) Nucleotide excision repair and human 
syndromes, Carcinogenesis 21, 453-460. 
5. Seroz, T., Winkler, G. S., Auriol, J., Verhage, R. A., Vermeulen, W., Smit, B., 
Brouwer, J., Eker, A. P., Weeda, G., Egly, J. M., and Hoeijmakers, J. H. (2000) 
Cloning of a human homolog of the yeast nucleotide excision repair gene MMS19 
and interaction with transcription repair factor TFIIH via the XPB and XPD 
helicases, Nucleic Acids Res 28, 4506-4513. 
6. Helleday, T., Petermann, E., Lundin, C., Hodgson, B., and Sharma, R. A. (2008) 
DNA repair pathways as targets for cancer therapy, Nat Rev Cancer 8, 193-204. 
7. Nick McElhinny, S. A., Watts, B. E., Kumar, D., Watt, D. L., Lundstrom, E. B., 
Burgers, P. M., Johansson, E., Chabes, A., and Kunkel, T. A. (2010) Abundant 
ribonucleotide incorporation into DNA by yeast replicative polymerases, Proc 
Natl Acad Sci U S A 107, 4949-4954. 
8. Goodman, M. F. (2002) Error-prone repair DNA polymerases in prokaryotes and 
eukaryotes, Annu Rev Biochem 71, 17-50. 
 24 
9. Jascur, T., and Boland, C. R. (2006) Structure and function of the components of 
the human DNA mismatch repair system, Int J Cancer 119, 2030-2035. 
10. Wyman, C., and Kanaar, R. (2006) DNA double-strand break repair: all's well 
that ends well, Annu Rev Genet 40, 363-383. 
11. Shrivastav, M., De Haro, L. P., and Nickoloff, J. A. (2008) Regulation of DNA 
double-strand break repair pathway choice, Cell Res 18, 134-147. 
12. Li, X., and Heyer, W. D. (2008) Homologous recombination in DNA repair and 
DNA damage tolerance, Cell Res 18, 99-113. 
13. Dubaele, S., Proietti De Santis, L., Bienstock, R. J., Keriel, A., Stefanini, M., Van 
Houten, B., and Egly, J. M. (2003) Basal transcription defect discriminates 
between xeroderma pigmentosum and trichothiodystrophy in XPD patients, Mol 
Cell 11, 1635-1646. 
14. Cleaver, J. E., Lam, E. T., and Revet, I. (2009) Disorders of nucleotide excision 
repair: the genetic and molecular basis of heterogeneity, Nat Rev Genet 10, 756-
768. 
15. Prakash, S., and Prakash, L. (2000) Nucleotide excision repair in yeast, Mutat Res 
451, 13-24. 
16. Boon, E. M., Ceres, D. M., Drummond, T. G., Hill, M. G., and Barton, J. K. 
(2000) Mutation detection by electrocatalysis at DNA-modified electrodes, Nat 
Biotechnol 18, 1096-1100. 
17. Liu, T., and Barton, J. K. (2005) DNA electrochemistry through the base pairs not 
the sugar-phosphate backbone, J Am Chem Soc 127, 10160-10161. 
 25 
18. Boal, A. K., and Barton, J. K. (2005) Electrochemical detection of lesions in 
DNA, Bioconjug Chem 16, 312-321. 
19. Slinker, J. D., Muren, N. B., Renfrew, S. E., and Barton, J. K. (2011) DNA charge 
transport over 34 nm, Nat Chem 3, 228-233. 
20. Ito, K., and Inaba, K. (2008) The disulfide bond formation (Dsb) system, Curr 
Opin Struct Biol 18, 450-458. 
21. Vlamis-Gardikas, A. (2008) The multiple functions of the thiol-based electron 
flow pathways of Escherichia coli: Eternal concepts revisited, Biochim Biophys 
Acta 1780, 1170-1200. 
22. Winterbourn, C. C., and Hampton, M. B. (2008) Thiol chemistry and specificity 
in redox signaling, Free Radic Biol Med 45, 549-561. 
23. Gorodetsky, A. A., Dietrich, L. E., Lee, P. E., Demple, B., Newman, D. K., and 
Barton, J. K. (2008) DNA binding shifts the redox potential of the transcription 
factor SoxR, Proc Natl Acad Sci U S A 105, 3684-3689. 
24. Lee, P. E., Demple, B., and Barton, J. K. (2009) DNA-mediated redox signaling 
for transcriptional activation of SoxR, Proc Natl Acad Sci U S A 106, 13164-
13168. 
25. Nunez, M. E., Noyes, K. T., and Barton, J. K. (2002) Oxidative charge transport 
through DNA in nucleosome core particles, Chem Biol 9, 403-415. 
26. Nunez, M. E., Holmquist, G. P., and Barton, J. K. (2001) Evidence for DNA 
charge transport in the nucleus, Biochemistry 40, 12465-12471. 
 26 
27. Gorodetsky, A. A., Ebrahim, A., and Barton, J. K. (2008) Electrical detection of 
TATA binding protein at DNA-modified microelectrodes, J Am Chem Soc 130, 
2924-2925. 
28. Boal, A. K., Genereux, J. C., Sontz, P. A., Gralnick, J. A., Newman, D. K., and 
Barton, J. K. (2009) Redox signaling between DNA repair proteins for efficient 
lesion detection, Proc Natl Acad Sci U S A 106, 15237-15242. 
29. Boal, A. K., Yavin, E., Lukianova, O. A., O'Shea, V. L., David, S. S., and Barton, 
J. K. (2005) DNA-bound redox activity of DNA repair glycosylases containing 
[4Fe-4S] clusters, Biochemistry 44, 8397-8407. 
30. Gorodetsky, A. A., Boal, A. K., and Barton, J. K. (2006) Direct electrochemistry 
of endonuclease III in the presence and absence of DNA, J Am Chem Soc 128, 
12082-12083. 
31. Romano, C. A., Sontz, P. A., and Barton, J. K. (2011) Mutants of the base 
excision repair glycosylase, endonuclease III: DNA charge transport as a first step 
in lesion detection, Biochemistry 50, 6133-6145. 
32. Sontz, P. A., Mui, T. P., Fuss, J. O., Tainer, J. A., and Barton, J. K. (2012) DNA 
charge transport as a first step in coordinating the detection of lesions by repair 
proteins, Proc Natl Acad Sci U S A 109, 1856-1861. 
 
 
Chapter 2 
 
 
 
 
 
 
 
 
ATP-stimulated, DNA-mediated redox signaling by XPD, a DNA repair and transcription 
helicase 
 
 
 
 
 
 
 
Adapted from Mui, T.P., Fuss, J.O., Ishida, J.P., Tainer, J.A., Barton, J.K. “ATP-
stimulated, DNA-mediated redox signaling by XPD, a DNA repair and transcription 
helicase” J. Am. Chem. Soc. 2011 133(41) 16378-81  
 
 
 
 
T.P.M. performed protein electrochemistry.  J.O.F. and J.P.I. generated protein and 
performed biochemical characterizations.
 28 
Introduction   
To protect the genome, a variety of proteins with various functions must act in 
concert.1-3 One such protein, XPD, is a super family 2 helicase critical to nucleotide 
excision repair (NER) and important to transcription.4-6 Helicases are responsible for 
unwinding DNA in an ATP-dependent fashion in order to access individual bases, 
allowing the other proteins to repair DNA damage, and to both replicate and transcribe 
DNA.   In humans, XPD is part of the TFIIH machinery, with single site mutations 
leading to human diseases with increased cancer risk or premature aging: Xeroderma 
Pigmentosum (XP), Cockayne Syndrome (CS), Trichothiodystrophy (TTD), or 
combinations thereof.4,5,7  Recent chemical analyses and crystal structures of archaeal 
XPD homologues, which have ~22% sequence identity with the human homologue, 
reveal the presence of a [4Fe-4S] cluster.8-10 Furthermore, combined structural, 
biochemical, and mutational analyses reveal that the catalytic core of XPD is conserved 
from archaea to humans and has functional relevance for understanding human disease.5 
Mutational analyses of [4Fe-4S] coordinating cysteines have established the importance 
of the [4Fe-4S] cluster in DNA unwinding activity,10-12 yet a role for XPD as a redox-
active protein remains to be established. 
DNA charge transport (CT), in which electrons are transferred between proteins 
bound to DNA in a path through the DNA bases, has been proposed as a first step in the 
localization of a family of base excision repair (BER) proteins containing [4Fe-4S] 
clusters in the vicinity of damage.13 DNA CT chemistry facilitates electron transfer over 
long molecular distances through the DNA duplex14,15 but is remarkably sensitive to 
perturbations in base pair stacking, as, for example, arise with damage.16,17  
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    DNA-mediated CT signaling by proteins was first explored in studies of a class of 
E. coli BER glycosylases that contain [4Fe-4S] clusters.18,19 Electrochemistry on DNA-
modified electrodes showed that DNA binding shifts the cluster potential to ~80 mV, 
well within the physiological range for redox signaling.  Biophysical experiments were 
then used to examine the redistribution of BER enzymes in the vicinity of damage, and 
genetic experiments were used to explore cooperative signaling between two BER 
enzymes, endonuclease (Endo) III and MutY.20,21 These results in combination with DNA 
electrochemistry connects the relocalization of Endo III (i) near a DNA mismatch (ii) to 
cooperate in helping MutY repair lesions in vivo, and (iii) to carry out DNA CT.  If CT is 
generally important for DNA repair, we hypothesized it should be detected in repair 
pathways besides BER, including NER, which is the major pathway for chemically 
modified bases that disrupt the DNA double helix.  
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Materials and Methods 
 Chemicals were purchased from Sigma Aldrich.  All reagents for DNA synthesis 
were purchased from Glen Research.  Gold on mica was purchased from Agilent 
Technologies.   
DNA Synthesis 
 DNA Sequences were synthesized using standard phosphoramidite chemistry at 
either IDT DNA (Coralville, IA) or on an Applied Biosystems 3400 DNA synthesizer.  
Thiol additions were introduced using disulfide phosphoramidites (Glen Research), 
which were subsequently reduced prior to experiment.  All oligonucleotides were purified 
by HPLC and confirmed by mass-spec. 
DNA Modfied Electrodes 
 
DNA modified electrodes were prepared as previously described. Briefly, a 50 µL 
solution of 50 mM duplex DNA (as determined by UV-Vis) was incubated on a bare 
gold-on-mica surface at 4°C overnight.  Free DNA was subsequently removed through 
rinsing of the  surface a minimum of three times with phosphate buffer (5 mM phosphate, 
50 mM NaCl, pH 7.0).  Next, 50 µL of a 1 mM 6-mercapto-1-hexanol solution in protein 
buffer was used to passivate the surface at ambient temperature for 2 hours.  Finally, the 
surface was rinsed a minimum of three times with protein buffer. 
Protein Expression 
 The Sulfolobus acidocaldarius XPD expression construct as described2 was 
modified to improve expression by removing a frame-shifting ATG start codon between 
the RBS and the correct start codon.  Mutants were then generated using Quikchange XL 
II kit (Stratagene) and verified by sequencing.  All proteins were expressed in BL21 
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Rosetta2 E. coli cells (Invitrogen) grown in Terrific Broth at 37ºC for 3 hours after 
induction with 0.2 mM IPTG.  Cells were resuspended in 20 mM MES pH 6, 100 mM 
NaCl, 1 mM DTT, 1 mM EDTA and lysed by sonication and constant cell disruptor 
(Constant Systems) at 20,000 psi.  After centrifugation at 29,000 RCF for 30 min, the 
supernatant was heat treated (65ºC, 20 min), centrifuged as before, and incubated with 
Capto DEAE (GE Healthcare) for 10-20 min at room temperature.  The flow-through was 
collected by gravity and loaded onto a 5 mL HiTrap Heparin (GE Healthcare) column at 
2 mL/min.  Bound protein was washed (7 column volumes) with lysis buffer and eluted 
with a linear gradient (7 column volumes) to 45% high salt buffer (20 mM MES pH 6, 1 
M NaCl, 1 mM DTT, 1 mM EDTA).  SaXPD-containing fractions (~36% high salt 
buffer) were pooled, concentrated using Amicon Ultra, Ultracel-10k regenerated 
cellulose spin filters, and fractionated on a HiLoad 16/60 Superdex200 (GE Healthcare) 
size exclusion column at 1 mL/min in 10.8% high salt buffer (200 mM NaCl final).  
SaXPD-containing fractions were pooled, concentrated as above to 2-12 mg/mL by 
OD280, and frozen.  All cell and protein manipulations were carried out at 4°C unless 
otherwise noted, buffers were filtered and degassed, and purification was carried out in 
one day when possible to limit oxygen exposure.    
Prior to electrochemical measurements, proteins were dialyzed against the protein 
buffer (20 mM Phosphate, 100 mM NaCl, 1 mM EDTA, 5% glyercol, pH 7.5) to remove 
residual DTT.  The concentration of individual proteins was determined by UV-Vis using 
ε=17,000 M-1 at 410 nM for the [4Fe-4S] cluster. For a representative trace, see Figure 
2.8.  The majority of the protein work was conducted in an oxygen-free environment to 
prevent degradation of the [4Fe-4S] cluster. 
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Protein Electrochemistry 
 Electrochemistry was performed as previously described1 with modifications 
indicated.  Measurements were obtained in an oxygen-free atmosphere using a CH 
Instruments 620C electrochemical analyzer.  A Au (111) surface served as the working 
electrode with a platinum wire auxiliary.  Ag/AgCl (Basi Electrodes) electrode was 
modified with a 4% agarose gel tip to serve as the reference.  The 3-electrode setup was 
placed in a humidifier box filled with degassed water to prevent evaporation of the 
protein from the electrode. Protein was added in aliquots of 40-50 µL with concentrations 
as indicated. 
Both ATP and ATP-γ-S were purchased from Sigma and dissolved in protein 
storage buffer to make 100 mM stock solutions that were subsequently degassed with 
argon. For ATP and ATP-γ-S additions, the appropriate degassed stock solution was 
added and mixed by pipetting.  
 For data analysis, current values were obtained by averaging the reductive sweep 
of a CV after linear base line corrections.  After equilibration on the surface, a linear fit 
was used as the background current.  The value of the current was then subtracted from 
the background current to obtain the difference in current.  This value was then 
normalized to the surface by dividing by the background current to obtain the % 
difference in current.  From the % difference in current data, 1st order kinetics were 
plotted to fit the parameters yield=1-e-kt. 
Biochemical Assays 
 
Helicase assays were performed as described2 with the following modifications.  
100 nM 5´-FAM-labeled DNA substrate and 50-500 nM XPD was used. Gels were 
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visualized and quantified using aVersaDoc MP 4000 Molecular Imager and Quantity One 
software, respectively (BioRad). 
 ATPase assays were carried out under the same conditions as the helicase assays, 
except that unlabeled ssDNA (25-mer from helicase substrate) was used and the total 
reaction volume was 50 µL. The amount of phosphate released was measured using 
Biomol Green Reagent (Enzo Life Sciences) according to the manufacturer’s instructions 
in 96-well plates on an Infinite M1000 microplate reader (Tecan).   
 SaXPD-DNA binding interactions were measured by fluorescence anisotropy 
(FA) as described2 with the following modifications: 20 nM substrate was used, reactions 
were incubated for 15 min, and FA was measured in 384-well plates using an Infinite 
M1000 microplate reader (Tecan). 
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Results and Discussion   
To determine if DNA CT might occur with XPD, we first found the DNA-bound 
redox potential of an archael XPD on DNA-modified gold electrodes (Figure 2.1 see 
Supporting Information for Methods). We found that XPD from the thermophile 
Sulfolobus acidocaldarius (SaXPD) has a DNA-bound redox potential of ~82 ± 10 mV 
versus NHE (Figure 2.1). This potential, like those found in BER proteins, reflects 
physiological redox activity and is not sufficient to damage DNA.18 Additionally, when a 
mismatch is introduced into the DNA duplex, the redox signal is significantly attenuated, 
consistent with the electrochemical protein signal being DNA-mediated (Figure 1).16 We 
also observed that the signal intensity exhibits a linear dependence on the square root of 
the scan rate, which implies that the protein is binding to DNA in a diffusion-limited 
process.22 In addition, we observed an electron transfer rate of approximately 1.4 s-1 
based on Laviron analysis, a similar value to previously published rates, indicating that 
the rate of electron transfer is limited by tunneling through the carbon linker.23 Together 
these data establish that this DNA-mediated signal corresponds to the one-electron redox 
couple of the [4Fe-4S] cluster of SaXPD bound to DNA, and that this redox couple can 
be physiologically active. 
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Figure 2.1 Cartoon Schematic of well-matched DNA with a 9 nucleotide single-stand 
overhang (left) and DNA with a CA mismatch (MM) (right).  
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Figure 2.2. Electrochemistry of DNA-bound WT SaXPD.  (Top) Cyclic voltammogram 
(CV) of SaXPD [120 µM] on a well-matched DNA-modified electrode (red) and on DNA 
with a CA mismatch located near the gold surface as in Scheme 1 (blue).  (Ag/AgCl 
reference electrodes; Pt auxiliary electrode, 50 mV/s scan rate, NHE = normal hydrogen 
electrode). (Bottom) Plot of current versus ν1/2 (square root of scan rate).  The data 
indicate that our signal is obtained through a diffusion-limited process. 
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Unlike BER glycosylases, the principal activity of the XPD helicase is ATP-
dependent, and as such, the effect of ATP on the DNA-bound signal could also be 
investigated.  After the protein was allowed to equilibrate on the DNA-modified surface, 
various concentrations of ATP or ATP-γ-S (a markedly slower to hydrolyze ATP 
analogue) were added (Figure 2.2, 2.5).24 Interestingly, as ATP was titrated onto the 
surface, a noticeable ATP-dependent increase in the current was observed.  No shift in 
potential was evident, indicating that the cluster is neither degraded nor markedly 
changed in its environment, and coupling to the DNA π-stack appears to increase.   
In contrast, the non-hydrolysable ATP analogue has little effect on the 
electrochemical signal of the protein, indicating that the electrochemical signal reports on 
the ATPase activity of XPD.  The sensitivity of the signal to ATP hydrolysis is 
remarkable given that, based on the crystal structure of the protein not bound to DNA, the 
distance between the cluster and the ATP binding site is 30 Å.10 However, in the XPD 
structure, the [4Fe-4S] cluster domain is tightly linked to the ATP binding site by β-
sheets that could provide a mechanism for mechanical coupling associated with motion 
between the cluster domain and the ATP site during hydrolysis.  The increase in 
electrochemical signal is likely reporting on motions at the protein/DNA interface as the 
protein carries out ATP hydrolysis. 
We additionally examined the effect of the DNA substrate (Figures 2.3 and 2.4), 
as XPD has shown a preference as a 5'-3' helicase.25 Modeled on a surface, the 5'-3' 
helicase would be expected, therefore, to move downward towards the surface.  As 
protein concentration is well above the dissociation constant (46 nM),10 it should bind 
DNAs with either 3'- or 5'-overhangs, as well as duplex DNA. Indeed, we see differences 
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in the DNA electrochemistry based on substrate. When protein is placed on the surface 
modified with DNA with a 3' ssDNA overhang, the signal increases temporarily, likely 
reflecting increased coupling, but then decreases over time. The decay may result from 
the protein sliding off the DNA-bound surface. Notably, the absolute signal could not be 
compared among the surfaces because of surface coverage variability.  On the fully 
duplexed surface, which has no directionality bias, we see a mixture of behaviors, which 
is what would be expected for non-specific binding by XPD. 
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Figure 2.3. ATP-dependent Electrochemistry of SaXPD on different DNA substrates. 
Time points shown are every 6 minutes. (Ag/AgCl reference electrode; Pt auxiliary 
electrode, 50 mV/s scan rate).  Percent difference in Current for SaXPD [9 µM] on a 5'-
ssDNA overhang (A), 3'-ssDNA overhang (B), fully duplexed DNA (C). The signal is 
ATP-dependent and sensitive to substrate. Note at the high concentration addition [5 mM 
ATP-γ-S], some ATP still remains, as once depleted, the signal levels off.  
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Figure 2.4  Plots as shown in Figure 2.3.  Arrows have been included during the ATP 
additions to indicate an initial phase as well as the evolution of the signal with ATP 
hydrolysis.   
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Figure 2.5.  ATP-dependent signal increase with 5 mM ATP addition.  Cathodic 
sweep of CVs for SaXPD [10 µM] on DNA modified electrodes pre and post [5 mM] 
ATP addition (left).  % difference in current versus time for SaXPD on DNA modified 
electrodes (right).  The arrow on the right indicates addition of 5 mM ATP.  Currents 
were obtained through averaging of the reductive sweep of the various voltammograms 
(Ag/AgCl reference electrode; Pt auxiliary electrode, 50 mV/s scan rate). 
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XPD mutations in humans are associated with several often fatal diseases, 
including XP, CS, and TTD.4,5,7 One such mutant, G34R, shows attenuated ATPase and 
helicase activity relative to wild type (WT) protein in biochemical assays.  Interestingly, 
this SaXPD mutant exhibits a redox signal comparable to that of WT in the absence of 
ATP (Table 2.1). However, the rate of electronic signal increase with ATP for the G34R 
mutant is significantly lower compared to WT, further demonstrating the sensitivity of 
our assay to ATP hydrolysis (Figure 2.6).   While there is certainly not a simple linear 
relationship between activity measured electrically and biochemically, the electronic 
signal appears to be a sensitive reporter of changes in protein/DNA coupling that result 
from ATP hydrolysis during the initial time following ATP addition. This assay 
complements a fluorescence helicase assay seen earlier, but without the need for DNA 
labeling.26 
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Figure 2.6. Electrochemical comparisons of SaXPD mutants after 5 mM ATP addition.  
(Top)  Crystal structure of SaXPD with residues that were mutated shown in space filling 
model. Also shown in space filling models is the [4Fe-4S] cluster  (Bottom), ATP-
dependent CT of WT (black), and G34R (red).  Observed initial rate constants (min-1) of 
0.29 and 0.08 for WT and G34R.      
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Mutant Redox 
Signal  
Intensity 
Helicase 
(bp/min) 
ATPase 
(mol/sec) 
ssDNA Kd (nM) 
WT 1 20.5 ± 0.7 1.24 ± 0.03 66 ± 5 
G34R 1.2 ± 0.09 0.8 ±0.1 0.0 ± 0.01 67 ± 3 
 
Table 2.1.  Redox and Biochemical activity of WT and G34R XPD.   
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Figure 2.7.  Electrochemistry of SaXPD on control surfaces.  Electrochemistry of 
SaXPD on a DNA modified electrode backfilled with mercaptohexanol (orange), on a 
mercaptohexanol only electrode (blue) and without SaXPD on a DNA modified electrode 
(red) (Ag/AgCl reference electrode; Pt auxiliary electrode, 50 mV/s scan rate).  These 
data indicate that this is a DNA-mediated process.   
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Figure 2.8.  UV-Vis spectrum of WT SaXPD.  The shoulder at 410 nm, is indicative of a 
[4Fe-4S] cluster and is used for determining the concentration of the XPD mutants. 
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Magnesium addition enhances ATP-dependent DNA-mediated signaling 
 SaXPD has exhibited a small dependence of ATPase activity on magnesium 
content.  As such, we tested the effect of Mg2+ on ATP hydrolysis.  Divalent cations 
typically serve to stabilize the hydrolyzed ATP intermediate and therefore facilitate 
cleavage of the triphosphate.  Similar to our ATPase assay, SaXPD was incubated on a 
surface and ATP was titrated in small increments.  After the ATP additions, 2 mM MgCl2 
was added, and CVs were taken every three minutes.  Our results in Figure 2.9 show that 
the addition of magnesium does in fact increase the redox active signal on the surface.  
This result demonstrates that the ATP-dependent DNA-mediated signaling has a small 
magnesium dependence.  However, due to assay constraints magnesium was omitted, as 
it provides only a negligible increase in the signal.   
SaXPD incubation on the surface 
 To verify that the observed signal increase was due only to the addition of ATP or 
ATP-γ-S, SaXPD was incubated on a DNA modified electrode for 7 hours, the time 
course of the ATP titration assay.  CVs were again taken every three minutes, and the 
data are shown in Figure 2.12.  Throughout the time course of the experiment there is 
little to no deviation from the linear increase in the signal, which is used as a background 
correction for all subsequent experiments.  Interestingly, even when the reference 
electrode is removed from solution and re-inserted, no increase in the redox signal is 
observed (data not shown).
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Figure 2.9  SaXPD on a DNA-modified electrode with ATP and magnesium additions. 
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SaXPD optimal substrate determination 
Helicases are responsible for unwinding the DNA and physically separating the 
complementary strands of DNA.  As a helicase, SaXPD has a substrate preference for 
ssDNA overhangs. In the past, DNA-modified electrodes assembled in the Barton lab 
focused on fully matched duplexes with either mismatches or different DNA damage 
products.  By utilizing a ssDNA overhang, we hypothesized that we would generate a 
preferred substrate for SaXPD and target the protein to the surface.  As shown in Figure 
10, we assembled a variety of DNA-modified electrodes and found that on a 9 nucleotide 
5ʹ′ ssDNA overhang we observed the largest signal.  Interestingly, on all of the substrates 
assayed we observed a redox signal.  This is attributed to the excess protein relative to the 
amount of DNA.  While the surface coverage is approximately 50 pmol/cm2, we observed 
non-specific DNA binding from the helicase.  
Optimizing protein concentration for electrochemical ATPase assay 
 Initial electrochemistry experiments required large concentrations (greater than 
100 µM) of protein to observe a redox active couple and verify that the observed protein 
signal was DNA-mediated.  When SaXPD was incubated on the electrode for 30 mins., 
signals of a few hundred nanoamps (nA) were observed.  (Figure 2.11)   Upon 5 mM 
ATP addition, the signal increase was quite negligible, only about 5%.  (Figure 2.11)  As 
a result, it was necessary to decrease the protein concentration on the surface to observe a 
greater increase in signal upon ATP addition.  Experiments were performed under 
varying SaXPD concentrations ranging from 2, 10, 40 and 160 µM, after which the 
protein was allowed to incubate for 90 mins., followed by three 60 min. titrations of 40 
µM, 1 mM, and 5 mM ATP.  As shown in Figure 2.11, the optimal signal increase 
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occurred at 10 µM SaXPD.  (Figure 2.11).   Based on this data, all further experiments 
utilized 10 µM as the protein concentration. 
 
Duplex Sequence 
Duplex DNA SH 5’ – GTGCTGCAACGTGTCTGCGC – 3’ 
   3’ – CACGACGTTGCACAGACGCG – 5’ 
Overhang DNA  SH 5’ – GTGCTGCAACGTGTCTGCGC – 3’ 
   3’ – CACGACGTTGCACAGACGCGAGAGCAGAC – 
5’ 
Overhang DNA w/MM 
(high) 
SH 5’ – GTGCCGCAACGTGTCTGCGC – 3’ 
   3’ – CACGACGTTGCACAGACGCGAGAGCAGAC – 
5’ 
Reverse DNA SH 5’ – CACGACGTTGCACAGACGCGAGAGCAGAC – 
3’ 
   3’ – GTGCTGCAACGTGTCTGCGC – 5’ 
Table 2.2.  Representative table of DNA duplexes utilized 
 
Figure 2.10 SaXPD on various DNA films. CVs of SaXPD [~120 µM] on various DNA 
modified electrodes as shown on the right.  In each case, the midpoint redox potential of 
the SaXPD protein is ~ 80 mV versus NHE. (shown versus Ag/AgCl).  Also note that in 
each case of the C:A mismatch, that the redox signal is significantly attenuated relative to 
the well-matched sequence, suggesting that the redox signal is DNA-mediated. 
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Figure 2.11.  Concentration dependent signaling of SaXPD on a DNA-modified 
electrode.  From top left clockwise SaXPD [40 µM, 2 µM, and 10µM] on a DNA 
modified electrode with a 5ʹ′ ssDNA overhang.  In each case the protein was allowed to 
equilibrate, followed by titrations of ATP-γ-S and ATP.  The top curves in each plot 
represent the raw current value obtained from the CV, while the bottom curves depict the 
change in current when background corrected.  Note at 10 µM SaXPD exhibits the largest 
increase in signal when ATP is added.
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Figure 2.12  Stability of SaXPD on a DNA-modified electrode.  SaXPD [10 µM] was 
incubated on a 5ʹ′-ssDNA overhang modified electrode for 6 hours with CVs taken every 
3 minutes.  Shown are the value of the currents from the reductive sweep over that same 
period.  Note the linear increase in signal of the protein over 6 hours.  This serves as a 
background correction in all future experiments. 
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Endonuclease III ATPase titration 
 Endonuclease III (EndoIII) has been extensively studied in our lab.  It was one of 
the first proteins identified to contain a [4Fe-4S] cluster and is capable of a DNA-bound 
reduction potential. As a glycosylase, EndoII is responsible for cleaving a mispaired 
adenone opposite a guanine.  Therefore it lacks ATP-depenedent helicase activity and is a 
great control for our reaction to verify that we are in fact observing ATP-dependent 
helicase activity in SaXPD.  As with our SaXPD experiments, EndoIII was incubated on 
the surface and followed by increasing titrations of first ATP-γ-S and ATP.  The redox 
signal grew in over time as expected with low-concentration proteins on DNA-modified 
electrodes (Figure 2.12); however, during each of the additions no noticeable increase 
was observed (Figure 2.12).  This verified that the increase in DNA mediated signaling 
observed with SaXPD was in fact a result of the SaXPD activity and not of the chemical 
additives.    
Bulk Electrolysis of SaXPD on DNA-modified electrodes 
 SaXPD exhibits similar redox properties as the previously reported BER proteins.  
It would be interesting if it too had a change in binding affinity associated with the redox 
state of the cluster.  This would allow SaXPD to signal other proteins through DNA-
mediated CT as proposed in the BER model.  To assay this, SaXPD was incubated on a 
DNA-modified electrode until the signal remained constant.  After equilibration, a fully 
reducing potential (-350 mV) was applied for 5 minutes and a CV was taken immediately 
after the bulk electrolysis.  As shown in Figure 2.13, we observed an increase in signal by 
10%.  The reverse was also performed; a fully oxidizing potential (50 mV) was again 
held for 5 minutes and a CV was immediately taken following the bulk electrolysis.  Here 
the signal decreased by 5%, suggesting that in the oxidized state, the protein has a higher 
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binding affinity for DNA than that in the reduced state, comparable with previously 
reported results for the EndoIII protein. 
  
Figure 2.13  Endonuclease III ATP-dependence.  Not all [4Fe-4S] cluster-containing 
redox active proteins demonstrate ATP-dependent signaling.  EndoIII [10µM] was 
incubated on a 5ʹ′-ssDNA overhang modified electrode and subject to an ATP and ATP-γ-
S titration.  (Left) Current or difference in current versus time for the EndoIII protein.  
(Right) Percent difference in current versus time for the EndoIII protein.  Notice that 
EndoIII signal does not change over time and grows in linearly, as expected with a 
protein that does not have ATP-dependent signaling.  This confirms that our ATP-
dependent signaling is unique to SaXPD and not a feature of all [4Fe-4S] cluster-
containing proteins. 
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Figure 2.14.   Bulk electrolysis of SaXPD.  CV after 5 minute Bulk Electrolysis of 
SaXPD at +50 mV (a), -350 mV (b), and +50 mV (c).  The orange curve represents the 
equillibrium prior to oxidation/reduction of the cluster.  
 
Δ  =11%  Δ  = -4%  
Δ  = 10%  
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SaXPD on HOPG Electrodes 
 As a final method of characterization of the SaXPD protein, we attempted to 
observe both the unbound and DNA-bound redox couples of SaXPD, which would allow 
for direct comparisons of the DNA-mediated signal and the surface bound signal.  DNA 
binding is thought to alter the potential of the cluster.  HOPG is better suited than gold for 
such measurements, as it can be scanned at a wider variety of potentials without 
damaging the surface.  On HOPG surfaces, pyrene modified DNA was used for self-
assembly, with octane as a back-filling agent.  However, we were never able to observe a 
redox couple for SaXPD from a wide range of concentrations (data not shown).  Surfaces 
were verified for integrity using Redmond red and methylene blue, however no protein 
signal ever emerged.  Attempts were made to observe the direct surface reduction of the 
[4Fe-4S] cluster.  Using HOPG without back-filling agent or DNA, we observed a redox 
signal at approximately -200 mV vs. NHE, which has been previously reported as the 
2+/1+ couple. (Figure 2.15)  Because of the difficulties in working with this surface, we 
abandoned attempts to observe the DNA-mediated signal from SaXPD on HOPG.   
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Figure 2.15.  CV of SaXPD on bare HOPG.  The 2+/1+ irreversible couple can be 
observed at -450 mV vs. Ag/AgCl. 
 
 
Figure 2.15 Electrochemistry of SaXPD on bare HOPG.  CV and Square Waves of 
SaXPD on bare HOPG (SP-3) showing that none of the individual components such as 
ATP (brown), ATP-γ-S (blue), or buffer (green) contribute to the irreversible peak 
observed at -450 mV vs. Ag/AgCl. 
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Light-activated ATP activation with SaXPD 
 One of the limitations of our electrochemical ATPase assay is that we must 
incubate the protein with ATP and it can, and presumably does, hydrolyze the ATP 
instantaneously.  To observe a synchrous ATP-dependent signaling event, we allowed 
SaXPD to incubate in the dark (to prevent uncaging) with DMPE-ATP, a light-activated 
caged ATP.  Upon irradiation, the DMPE group was removed and ATP exposed.    As 
shown in Figure 2.16, upon irradiation, we saw a large increase in the electrochemical 
signal.  However, this signal is large, erratic, and decays quickly.  This experiment was 
repeated with only DMPE-ATP on a DNA-modified electrode and upon irradiation a 
similar effect was observed.  Therefore, the photo release of the DMPE provides a redox 
active molecule that interferes with monitoring of the SaXPD DNA-mediated signal. 
Identification of a photo protected ATP that is not redox active would enable the 
observation of synchrous signaling by the SaXPD helicase. 
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Figure 2.16 Light-activated ATP electrochemisty.  (Top) Chemical structure of the 
DMPE-ATP used in all light-activated ATP studies.  (Top right) Plot of current versus 
time for DMPE on a DNA-modified electrode.  Note that as the DMPE-equilibrates on 
the electrode a small current is observed, followed by a large spike when the ATP is 
activated with 254 nm light (black curve).  (Top Right)  When protein is incubated on the 
surface with 10 mM DMPE, the signal is larger, and attributed to the [4Fe-4S] cluster, 
however upon photoactivation (orange), a large redox peak is activated due to the DMPE 
group.  (Bottom Left) CVs for DNA-modified electrod when UV light is exposed to the 
surface.  Note that no redox active peaks are present.  (Bottom Right)  CVs of DMPE on 
a DNA modified electrode.  Note that, upon photorelease of the DMPE group, a large 
irreversible redox couple emerges.  Decoupling this redox peak from the [4Fe-4S] cluster 
is a challenge and will not be pursued
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Conclusions 
XPD, a critical helicase for NER, contains a redox-active [4Fe-4S] cluster that is 
sensed electronically as a reporter of ATPase/helicase activity.  The DNA-bound redox 
potential is similar to previously reported BER proteins.  Here, DNA electrochemistry 
provides a sensitive means for detecting ATP-dependent signaling that may be generally 
useful in screening the activity of DNA-binding proteins containing redox centers.  The 
activity can be distinguished between the WT protein and ATP-deficient activity of the 
G34R mutant, as well as between the native and non-native DNA substrates.   
Furthermore, attempts were made to coordinate ATP signaling using a light-activated 
ATP, which was redox active. Additionally, these results prompt the question as to how 
this electronic signaling of XPD activity might be utilized in vivo, and further, to which 
proteins XPD may be signaling inside the cell.  Various repair and replication proteins, 
including FancJ and Dna2, which act in maintaining genomic stability, also have an 
associated [4Fe-4S] cluster.27,28 We suggest that it will be important to test other proteins 
acting at the interface of repair with major DNA processes of replication and 
transcription for their CT ability.  
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Chapter 3 
 
 
 
 
 
 
 
 
 
Charge transfer properties of mutants related to the human diseases xeroderma 
pigmentosum, cockayne syndome, and trichothiodrystrophy in the [4Fe-4S] cluster-
containing helicase XPD from Sulfolobus acidocaldarius  
 
 
 
 
 
 
 
 
T.P.M. and Winnie Wang performed electrochemistry.  J.O.F. and J.P.I. purified protein 
and performed biochemical characterizations. 
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Introduction 
 DNA charge transfer (CT) is the phenomenon by which electrons are transferred 
through the π-stacked bases of DNA (1).  This process is exquisitely sensitive, as 
perturbations to individual base pairs alter the geometry of the π-stack dramatically, 
thereby attenuating the conductivity of the DNA “wire.”  However, nicks in the sugar 
phosphate backbone do not affect this process (2).  Double-stranded DNA in a variety of 
conformations, including G-quadruplexes and Holliday junctions, has been shown to 
conduct charge (3-6).  Recently, a model was proposed whereby redox-active proteins 
utilize DNA-mediated CT to localize near the site of DNA lesions because of the 
attenuation of CT at these sites.  In the model system, MutY and EndoIII, two base 
excision repair (BER) proteins from E. coli, are activated towards oxidation upon DNA 
binding.  Protein oxidation releases an electron to a distally bound protein, which, upon 
reduction, dissociates from the DNA.  However, if an intervening lesion is present, this 
electron transport process can no longer occur, and the repair proteins remain bound to 
the DNA and eventually progress towards the lesion (7-10).   
 To observe this model in an in vitro system, mutants of endonuclease III (EndoIII) 
with varying CT proficiencies were identified (11).  CT proficiency was measured on 
DNA-modified electrodes. An atomic force microscopy assay (AFM) that measures 
protein distribution onto DNA strands that are either completely well-matched or contain 
a single C:A mismatch showed that the mutants with enhanced CT proficiency increased 
the redistribution of these proteins towards sites of DNA damage, while mutations that 
were CT-deficient showed a reduced preference towards lesions (11).  This assay 
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demonstrated the importance of protein signaling via DNA-mediated CT for redox-active 
proteins to localize at lesions. 
 Sulfolobus acidocaldarius (Sa)XPD has recently been identified as a [4Fe-4S] 
cluster-containing protein (12-14), which binds DNA and exhibits a DNA-bound redox 
potential of 80 mV versus NHE, similar to the BER proteins previously described (15).  
This protein was furthermore found to exhibit an ATP-dependent increase in electronic 
signaling.  XPD is essential for nucleotide excision repair (NER) and XPD deletions are 
inviable in mice (16, 17).  Mutations in XPD are linked to the diseases xeroderma 
pigmentosum, trichothiodystrophy, and cockayne syndrome.  In patients, these mutations 
lead to progeria and often cancers (16, 18-22).  Many of these mutant proteins have been 
studied in cellular extracts from patients, but, the activities of the individual protein 
mutants have yet to be assayed (18, 20).  While it is a thermophile, SaXPD is a good 
model system, as many of the mutations found in the human XPD protein share 
homology with SaXPD (14, 22).    
 In this work, we describe both the biochemical and electrochemical 
characterization of single-point mutants of SaXPD that are disease related in humans.  
We further explore how electrochemical signaling in each of these mutants may 
contribute to the deficiencies that lead to human disease. 
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Materials and Methods  
 Chemicals were purchased from Sigma Aldrich.  All reagents for DNA synthesis 
were purchased from Glen Research.  Gold on mica was purchased from Agilent 
Technologies.   
Protein purification 
The Sulfolobus acidocaldarius XPD expression construct as described was 
modified to improve expression by removing a frame-shifting ATG start codon between 
the RBS and the correct start codon (14).  Mutants were then generated using quikchange 
XL II kit (Stratagene) and verified by sequencing.  All proteins were expressed in BL21 
Rosetta2 E. coli cells (Invitrogen) grown in Terrific Broth at 37ºC for 3 hours after 
induction with 0.2 mM IPTG.  Cells were resuspended in 20 mM MES (pH 6.0), 100 mM 
NaCl, 1 mM DTT, 1 mM EDTA and lysed by sonication and constant cell disruptor 
(Constant Systems) at 20,000 psi.  After centrifugation at 29,000 RCF for 30 min, the 
supernatant was heat treated (65ºC, 20 min), centrifuged as before, and incubated with 
Capto DEAE (GE Healthcare) for 10-20 min at room temperature.  The flow-through was 
collected by gravity and loaded onto a 5 mL HiTrap Heparin (GE Healthcare) column at 
2 mL/min.  Bound protein was washed (7 column volumes) with lysis buffer and eluted 
with a linear gradient (7 column volumes) to 45% high salt buffer (20 mM MES pH 6, 1 
M NaCl, 1 mM DTT, 1 mM EDTA).  SaXPD-containing fractions (~36% high salt 
buffer) were pooled, concentrated using Amicon Ultra Ultracel-10k regenerated cellulose 
spin filters, and fractionated on a HiLoad 16/60 Superdex200 (GE Healthcare) size 
exclusion column at 1 mL/min in 10.8% high salt buffer (200 mM NaCl final).  SaXPD-
containing fractions were pooled, concentrated as above to 2-12 mg/mL by OD280, and 
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frozen.  All cell and protein manipulations were carried out at 4°C unless otherwise 
noted, buffers were filtered and degassed, and purification was carried out in one day 
when possible to limit oxygen exposure.    
Prior to electrochemical measurements, proteins were dialyzed against the protein 
buffer (20 mM Phosphate, 100 mM NaCl, 1 mM EDTA, 5% glyercol, pH 7.5) to remove 
residual DTT.  The concentration of individual proteins was determined by UV-Vis using 
ε=17,000 M-1 at 410 nM for the [4Fe-4S] cluster (Figure 3.1). The majority of the protein 
work was conducted in an oxygen-free environment to prevent degradation of the [4Fe-
4S] cluster. 
ATPase assay 
 ATPase activity was measured by monitoring production of free phosphate 
catalyzed by the hydrolysis of ATP using the Biomol Green Reagent (Enzo Life 
Sciences).  In a 96-well plate, 50 µL of 20 nM ssDNA, 50 µM ATP, 25 nM Rad3 was 
incubated in assay buffer (50 mM Tris pH 8.0, 0.1 mg/mL BSA, 2 mM MgCl2) for 60 
minutes at 30°C.  Reactions were quenched with 100 µL of Biomol Green Reagent, 
incubated at room temperature to allow the reagent to develop, and absorbances were 
measured using a plate reader with 630 nm filter cut-off.  ATPase activity was 
determined by comparing absorbance values against a standard curve. 
Helicase Assay 
 Cy5- and Iowa Black Dark-modified DNAs were ordered from IDT DNA 
(Coralville, IA).  DNA was annealed in phosphate buffer (20 mM phosphate, 50 mM 
NaCl, pH 7.5).  Duplexes were quantified by UV-visible spectroscopy and diluted to 
reach a final concentration of 1µM.  Using a Bio-Rad 96-well plate fluorescent 
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themocycler reader, 30 µL reactions of 5 nM duplex, 500 µM ATP, and 300 nM Rad3 
were incubated in assay buffer and monitored over one hour with scans taken every 30 
seconds.  Reactions were initiated by addition of ATP.  Helicase activity was measured 
and fit to first-order kinetics to determine rate constants. 
DNA-binding experiments 
 Fluorescence anisotropy was measured using a Flexstation 3 instrument.  Rad3-
DNA interactions were proved in a reaction mixture of assay buffer with 10 nM 
fluorescein-labeled DNA (IDT DNA) in 20 µL reactions using the substrate 
5ʹ′(fam)CACGTTGACTACCGTC -3ʹ′.  The protein-DNA mixture was incubated at 30°C 
for 20 minutes, and fluorescence was monitored at 520 nm for in 30-second intervals for 
5 minutes.  Polarization data was measured in triplicate and fit to a 4-parameter hill 
coefficient to determine ssDNA binding constants using kaleidagraph. 
DNA synthesis 
 DNA was synthesized as previously described.  Standard phosphoramidites were 
used on an ABI 3400 DNA synthesizer with modifications from Glen Research.  DNA 
was purified by reverse-phase HPLC, and solvent removed through lyophilization.  
Disuflide-modified DNA was resuspended in 400 µL reduction buffer (50 mM Tris, pH 
8.0) and reduced with 10 mg of DTT.  DNA quantification was based on UV-visible 
absorbances at 260 nm.   
DNA-modified electrochemistry 
Duplex DNA [50 µM] with a 5ʹ′ ssDNA overhang was annealed in degassed 
phosphate buffer (50 mM phosphate, 100 mM NaCl, 1 mM EDTA, pH 7.5) and allowed 
to self-assemble on a gold-on-mica surface overnight (Agilent technologies).  Excess 
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DNA was washed a minimum of three times from the surface with phosphate buffer.  The 
surface was then backfilled with a solution of 1 µM mercaptohexanol in protein buffer 
(200 mM NaCl, 50 mM Tris, pH 8.0, 1 mM EDTA and 5% glycerol).   Protein was added 
to the electrode housing, and electrochemistry was performed using a CH Instruments 
600 potentiostat and a 3-electrode set-up with a Ag/AgCl reference electrode, platinum 
auxiliary, and DNA-modified electrode as the working surface.  All measurements were 
performed in a glovebag with 2% hydrogen and 98% nitrogen to prevent degradation of 
the protein cluster and minimize the presence of oxygen.  
For data analysis, current values were obtained by averaging the reductive sweep 
of a CV after linear base line corrections.  After equilibration on the surface, a linear fit 
was used as the background current.  The value of the current was then subtracted from 
the background current to obtain the difference in current.  This value was then 
normalized to the surface by dividing by the background current to obtain the % 
difference in current.  From the % difference in current data, 1st order kinetics were 
plotted to fit the parameters yield=1-e-kt. 
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Results 
SaXPD single point mutations: biochemical and electrochemical characterization 
 SaXPD protein mutants were overexpressed and purified.  Individual mutations 
were made on a plasmid through site-directed mutagenesis.   Proteins were dialyzed 
against protein buffer (200 mM NaCl, 1 mM EDTA, 20 mM Triza-HCl pH 8.0) to 
remove residual DTT.  Helicase, ATPase, and DNA-binding activities were assayed to 
determine the activities of each protein mutant (Table 3.1).  All mutants show ssDNA 
binding constants between 60 – 80 nM.  ATPase activity was observed in the WT and 
Y104A mutants, while no activity was observed for the R460P and G34R mutants.  The 
L325V, R460W, and K84C mutants retained 43%, 11%, and 49% of WT ATPase 
activity, respectively.  None of the mutants exhibited helicase activity comparable to the 
WT protein.  However, the L325V, R460W, and Y104A mutants retained 66%, 64%, and 
49% of WT helicase activity, respectively, while the R460P, G34R, and K84C mutants 
showed less than 10% of WT activity (Table 3.1).   
Prior to electrochemical experiments, the protein was quantified by UV-Vis using 
the absorbance at 410 nm, indicative of the [4Fe-4S] cluster (Figure 3.1).  A structure of 
the SaXPD protein with the relevant single point mutations is shown in Figure 3.3B.  We 
have developed an electrochemical assay for ATPase activity using DNA-modified 
electrodes.  To verify the ATPase activity of these newly-generated disease-related 
mutants, proteins were incubated on a DNA-modified electrode, and various 
concentrations of ATP or ATP-γ-S were added.  When ATP-γ-S was added, no increase 
in current was observed, as ATP-γ-S is a more slowly hydrolysable ATP analogue.  
However, upon 5 mM ATP addition, an increase in the electrochemical signal intensity 
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was observed (Figure 3.2A).  The ATPase and helicase deficient G34R mutant shows no 
noticeable increase, while the Y104A mutant (which is not a disease-related mutant) 
exhibits kinetics similar to the WT protein.  The K84C mutant, which is helicase 
proficient but ATPase deficient, shows an electronic signal increase between the WT and 
G34R mutant upon addition of 5 mM ATP (Table 3.1, Figure 3.2A). 
To determine the efficiency of DNA-mediated charge transfer for each of these 
individual mutants, each protein (~10 µM) was incubated on a DNA-modified electrode, 
and cyclic voltammagrams (CVs) were taken every 3 minutes.  The surface was rinsed, 
and subsequently scanned to verify that any residual protein was removed.  This process 
was repeated for each of the protein mutants.  While the magnitudes of the currents 
varied, each protein retained the same mid-point redox potential of ~80 mV versus NHE.  
Current intensities were determined for each of the protein mutants and normalized to 
[4Fe-4S] cluster content (Figure 3.2D).  All mutants made have been implicated in 
human disease, with the exception of the Y104A mutant, which was generated to explore 
the CT pathway in the protein.  This mutant exhibited an electrochemical signal much 
larger than that of the WT protein (approximately 2-5 times larger).  Similarly, the K84H 
mutant, a mutant implicated in disease, exhibits a signal larger than WT (Figure 3.2D).  
The G34R mutant, which is ATPase and helicase deficient, exhibits a signal comparable 
to the WT protein (Figure 3.2D). As predicted in our model for communication between 
proteins, a larger redox signal would translate into more efficient CT between proteins.    
We have identified a variety of protein mutants implicated in either TTD, XP, or 
XP and CS with ATPase and helicase activities, DNA binding affinities, and TFIIH 
complex forming abilities comparable to WT.   However, when placed on our DNA-
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modified electrodes, the R460P, R460W, L325V, and A511R mutants exhibit protein 
signals two to three times lower than that of the WT protein.  While these proteins have 
some variation in ATPase and helicase activity (Table 3.1), their activities are within that 
of the WT protein.  The only difference appears to be the protein mutants’ ability to 
signal one another by DNA-mediated CT.  This electrochemical defect represents the 
intriguing possibility that could explain why these mutants lead to human disease.
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Figure 3.1.  UV-Vis of various SaXPD mutants.  L325V (black), R460P (purple), 
R460W (blue), and A511R (green) all show a characteristic absorbance at 410 nm, 
indicative of a [4Fe-4S] cluster.  Based on this absorbance, a concentration can be 
determined using ε = 17,000 M-1 
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Mutant Human Electrochemical 
signal intensity 
(relative to wt) 
Helicase 
bp/min (%wt) 
ATPase 
mol/sec 
(%wt) 
ssDNA Kd 
(nM) (%wt) 
WT -- -- 10.7 ± 0.95 
(100%) 
0.81 ± 0.03 
(100%) 
66.0 ± 5.4 
(100%) 
L325V L461V 0.31 ± 0.07 7.13 ± 0.32 
(66%) 
0.35 ± 0.02 
(43%) 
69.3 ± 7.8 
(95%) 
R460W R616W 0.26 ± 0.06 6.83 ± 0.10 
(64%) 
0.092 ± 0.005 
(11%) 
66.7 ± 10 
(99%) 
R460P R616P 0.39 ± 0.07 0.75 ± 0.42 
(7%) 
0.012 ± 0.003 
(1.4%) 
79.3 ± 2.7 
(80%) 
G34R G47R 1.19 ± 0.13 0.98 ± 0.53 
(9%) 
0.002 ± 0.001 
(0%) 
66.8 ± 2.7 
(99%) 
K84C R112C 3.87 ± 0.81 0.90 ± 0.42 
(8%) 
0.39 ± 0.05 
(49%) 
79.8 ± 0.35 
(79%) 
Y104A H155 5.94 ± 1.42 5.3 ± 0.42 
(49%) 
0.89 ± 0.12 
(110%) 
60.7 ± 6.4 
(108%) 
Table 3.1.  Biochemical activity of single SaXPD mutants.  CT signal proficiency, 
helicase, ATPase, and ssDNA binding for the various SaXPD mutants and their 
corresponding human mutations shown.  Data from (23) or obtained from the Tainer lab. 
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Figure 3.2.  Electrochemical signal for various SaXPD single mutants. A.  ATPase 
activity of WT, Y104A, K84C, and G34R SaXPD on a DNA modified electrode after 5 
mM ATP addition.  B.  Crystal structure of SaXPD with mutations highlighted as colored 
spheres.  C.  CV of various SaXPD mutants Y104A (green), WT (black), G34R (pink), 
and L325V (red) after 90 minutes on the DNA-modified electrodes.  D.  Quantification of 
the various SaXPD electrochemical signals on the same DNA modified electrode 
compared to WT SaXPD signal. 
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Double mutant electrochemistry to restore CT to single point mutants 
 
Mutations in SaXPD are thought to be conserved between archaea, yeast, and 
humans, and our electrochemical data suggested that CT-deficiency may be related to 
disease.  With the intent to restore CT to the CT-deficient disease-related mutants, 
L325V, R460P, R460W, we combined the enhanced CT-proficient Y104A mutation with 
each of these single point mutants.  The newly generated Y104A/L325V, Y104A/R460P, 
and Y104A/R460W double mutants were then quantified by UV-Vis, and their 
electrochemical signals were normalized to [4Fe-4S] cluster content.  The protein 
mutants were incubated on a DNA-modified electrode for 90 minutes, with CV scans 
taken every 3 minutes.  The CV was then background corrected and quantified to obtain a 
value for the current.  These signals were then averaged and compared to the WT signal, 
and error was determined from the deviation at each timepoint. Relative current intensity 
is shown in Figure 3.3 and is normalized to the WT signal.  Each of the double mutants 
exhibited a redox signal lower than not only the WT protein, but also the single CT-
deficient L325V mutant.  As a control the Y104A and L325V single point mutations 
were also assayed and displayed an enhanced and reduced signal, respectively.  These 
results suggest that, while each single mutant has a particular property of interest, the 
combination of two mutations does not lead to a combined restorative effect. 
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Figure 3.3.  Double mutant SaXPD electrochemistry.  Relative current intensity for the 
SaXPD double mutants, Y104A (yellow), L325V (green), Y104A/R460W (black), 
Y104A/L325V (red), and Y104A/R460P (blue) SaXPD protein mutants on a DNA-
modified electrode.   
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Modeling a double mutant to restore CT to the deficient L325V mutant in SaXPD 
The SaXPD crystal structure provides a wealth of information about protein 
tertiary structure, as well as potential interactions between neighboring amino acid 
residues.  From models based on the crystal structure, it appears that a leucine (Figure 3.4 
A, orange spheres) to valine (Figure 3.4 B, green spheres) mutation at position 325 
creates a steric clash with methionine 331 (Figure 3.4, red spheres).  This interaction 
could explain the CT-deficiency of the L325V mutant, as the residues surrounding the 
mutation may have altered positions in order to accommodate the steric clash.  Based on 
this interaction, the methionine was reduced to an alanine to generate the combined 
L325V/M331A double mutant (Figure 3.5A).   
Prior to all electrochemistry experiments, protein mutant concentrations were 
quantified based on their absorbance at 410 nm.  These mutants were incubated on a 
DNA-modified electrode for 90 minutes, with CV scans taken every 3 minutes.  On the 
electrode, these mutants all exhibited a DNA-bound redox potential of 80 mV versus 
NHE.  The WT protein exhibited an average current intensity of 67.6 ± 6.4 nA. The 
L325V mutant showed a current intensity of 69.7 ± 3.8 nA compared to 49.6 ± 3.4 nA for 
the M331A mutant.  The L325V/M331A double mutant exhibited an intensity of 85 ± 6.1 
nA on the same surface (Figure 3.5c).  The L325V and L325V/M331A were purified 
using a new purification protocol independent of the WT SaXPD and, as a result, may 
lead to different CT proficiencies because of impurities associated with the newer 
purification or decreased binding in the WT protein over time.   
Finally, these mutants were electronically assayed for their ATPase activity as 
previously reported.  Briefly, the protein was allowed to incubate for 90 minutes on the 
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electrode.  ATP-γ-S, a slowly hydrolysable ATP analogue, was added to the electrode 
first to verify that the signal does not increase with the addition of the ATP-mimic.  
Increasing amounts of ATP were then added during 60-minute intervals, with CVs taken 
every 3 minutes.  Finally, a large amount of ATP-γ-S was added to verify that any signal 
increases were due to ATP hydrolysis.    Figure 3.5D shows the effect of 5 mM ATP 
addition on the electrochemical signal for each of these mutants.  Both the WT and 
L325V mutant have electronic ATPase activity consistent with in vitro assays (Table 
3.1).  However, the L325V/M331A mutant shows a diminished ATPase activity 
comparable to the G34R mutant (Figure 3.2A).  The M331A mutant lacks both ATPase 
and helicase activity in vitro (data not shown), which potentially explains why the 
L325V/M331A mutation shows minimal electronic ATPase activity.   
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A. 
 
B. 
 
Figure 3.4 Pymol model of SaXPD for L325V mutation.  A. WT SaXPD crystal 
structure with L325 (orange) and M331 (red) residues highlighted. B.  SaXPD crystal 
structure with L325V (green) and M331 (red) residues highlighted.  Both structures are 
from PDB ID 3CRV. 
 
 
 
 
 
 82 
 
 
A. 
 
B. 
 
C. 
 
D. 
 
Figure 3.5 Modeled repair of L325V SaXPD mutation.  A.  Crystal structure of 
SaXPD (PDB ID 3CRV) with L325V (orange) mutations.  Interactive residues are shown 
in yellow and blue.  An M331A mutation (blue and gray) is shown where the methionine 
is reduced to an alanine to prevent steric interactions with L325V.  B.  UV-Vis of the WT 
(black), L325V/M331A (red), L325V (blue), and M331A (yellow) SaXPD mutants using 
the 410 nm absorbance for quantification.  C.  Average current signal for the SaXPD 
L325V (red), L325V/M331A (blue), M331A (yellow), and WT (black) mutants after 90 
minute incubation on a DNA-modified electrode.  The signal for the double mutants is 
approximately 10% larger than the single L325V mutant.   D.   Percent difference in 
current over time for the various SaXPD mutants upon 5 mM ATP addition.
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Discussion 
The XPD family of helicases is essential for nucleotide excision repair (NER).  
These proteins are well conserved between species, and mutations from human XPD that 
lead to disease are found in S. acidocaldarius XPD.  Using DNA-modified electrodes, we 
assayed the single point disease-relevant G34R, K84C, L325V, R460P, R460W, and 
A511R mutants as well as the artificially designed Y104A mutant.  These mutants all 
contain a [4Fe-4S] cluster similar to the WT protein, as evidenced by UV-Visible 
spectroscopy.  When characterized biochemically, the G34R, R460P, and A511R mutants 
lack both ATPase and helicase activity, which are required for NER.  However, the 
K84C, L325V, R460W, and Y104A mutants exhibit activities significantly closer to the 
WT protein.  Mutations affecting the biochemical activity of XPD explain how these 
mutants lead to the human diseases associated with XP proteins. However, the reason 
why K84C, L325V, and R460W all lead to disease are as yet unknown.  
 On a DNA-modified electrode all protein mutants exhibited a DNA-bound redox 
potential of 80 mV versus NHE.  When assayed electronically for ATPase activity, the 
WT, Y104A, and L325V showed similar activity, while the ATPase deficient G34R, 
R460P, and A511R mutants showed minimal ATPase activity.  The K84C mutation, 
which is helicase deficient but ATPase proficient, showed mediocre activity.  Therefore, 
our electronic DNA-mediated ATPase assay agrees with other in vitro ATPase assays.  
This assay does not require labeling of DNA or the protein and simply monitors increases 
in electronic signaling. 
 Protein coupling into the DNA π-stack is another mechanism by which proteins 
can utilize these redox-active [4Fe-4S] clusters to communicate with one another.  For 
each of these mutants, we additionally compared the signals from each of the individual 
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protein mutants.  Both the WT and G34R mutant showed similar signals, but the disease-
relevant L325V, R460P, R460W, and A511R mutants exhibited attenuated redox signals 
compared to the WT protein.  Poor coupling into the DNA π-stack potentially explains 
how mutants such as L325V and R460W, which both have ATPase and helicase activity, 
lead to disease.   
 To determine if multiple mutations lead to additive effects on DNA CT, double 
mutants of a CT-enhanced Y104A mutant with each of the CT-deficient L325V, R460W, 
and R460P mutations were made.  When assayed electrochemically, these mutations 
exhibited signals lower than any of the single point mutations.  Therefore, in this system, 
additive effects were not observed when combining CT-enhanced mutations with those 
that are CT-deficient.     
 Based on the SaXPD crystal structure, a steric interaction was identified in the 
L325V mutant with M331.  Steric interactions can cause local structure disruption, which 
can orient the cluster further from the DNA, thus attenuating coupling between the [4Fe-
4S] cluster and the π-stack.  To reduce this interaction, an L325V/M331A double mutant 
was generated.  When assayed for electronic ATPase activity, this mutant exhibited 
negligible activity.  The M331A mutation lacks both ATPase and helicase activity, which 
explains why when combined with L325V, this double mutant lacks activity.  However, 
when assayed for electronic signaling, this mutant exhibits a 10% higher electronic signal 
compared to the single L325V mutation.  These results are inconclusive, because the 
L325V mutation no longer appears to be CT-deficient compared to the WT protein, 
possibly due to a new purification scheme or diminished DNA binding of the WT protein 
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over time.  However, the L325V/M331A mutant exhibits a larger redox signal compared 
to the single L325V mutant, so the in vivo effects of this double mutant are unknown.   
Biochemically, double mutants appear to have non-additive effects.  In fact, the 
Y104A/L325V, Y104A/R460P, and Y104A/R460W double mutants exhibited a 
destabilization.  However, mutations in SaXPD appear to have a large effect on CT 
proficiency for the disease-related mutations.  For each of these mutants, we were able to 
observe both electronic signals and electronic ATPase activity that correlated well with 
solution-based ATPase assays.  Our electrochemical results provide an explanation for 
how mutations proficient in both ATPase and helicase activity can lead to disease.  The 
L325V and R460W mutants, which are both biochemically active, show reduced 
electronic signaling.  These mutations would therefore be interesting to study in vivo 
using a system more closely related to humans, such as the yeast Saccharomyces 
cerevisiae with the XPD homologue Rad3.    
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containing Rad3 helicase from Saccharomyces cerevisiae  
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Introduction 
DNA is constantly being damaged by exogenous sources, and a complete 
understanding of the proteins involved in DNA repair is essential.  Damage leading to 
mutations, premature aging, or even cancer is repaired by a variety of pathways, 
including base excision repair (BER), mismatch Repair (MMR), double strand break 
repair (DSBR), and nucleotide excision repair (NER).  Proteins must quickly and 
efficiently localize to the site of damage and coordinate repair (1, 2). Each of these 
individual repair processes is well characterized, with models to describe the repair 
events (3-7).   
The XPD family of proteins is well conserved, with homologues found 
throughout the eukaryotes.  XPD is a SF2b 5ʹ′-3ʹ′ helicase that is part of TFIIH required 
for NER (8-13).  Mutations in human XPD result in the fatal diseases xeroderma 
pigmentosum, cockayne syndrome, and/or trichothiodystrophy (5, 14). It is somewhat 
surprising that one gene can lead to so many different disease states, but not that helicases 
play such a large role in DNA repair (14-16). Recently, XPD from three different 
thermophiles was crystallized and shown to contain a redox-active [4Fe-4S] cluster (17-
19). The XPD protein from Sulfolobus acidocaldarius exhibits ATP-dependent DNA-
mediated signaling via the cluster, which may also be involved in signaling to other 
proteins for DNA repair (20). Researchers further characterized the activity of the human 
disease-related mutants.  Unsurprisingly, most disease-related mutants exhibited either 
ATPase or helicase deficiencies.   A majority of the knowledge of the XPD protein 
function is based on either purified homologous thermophilic proteins, cellular extracts 
from human cell lines, or other eukaryotes (8-12, 21, 22).   
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 Redox-active metalloproteins have recently been implicated in DNA repair, as the 
BER glycosyslases, Endonuclease III and MutY, as well as the NER helicase XPD have 
been shown to contain a redox-active [4Fe-4S] cluster with a reversible DNA-bound 
potential of ~80 mV versus NHE (20, 23, 24). A model was proposed whereby these 
proteins can communicate with one another through DNA-mediated charge transport 
(CT), where electron transfer can occur through the π-stacked bases of undamaged DNA. 
In the case of a lesion, DNA CT does not occur, thus facilitating the localization of 
proteins near the site of DNA damage (23, 25, 26).  In an AFM assay measuring the 
redistribution of these [4Fe-4S] cluster-containing proteins, it was observed that these 
proteins redistribute towards mismatched sites, a type of lesion that attenuates CT.  
However, with CT-deficient mutants, no such redistribution occurs (25-28).  
Furthermore, DNA-mediated CT has been shown in mitochondria and nucleosomes, and 
is involved with the transcription factor SoxR(24, 29).  
 The thermophilic protein system is useful for determining the individual effects of 
mutations in SaXPD; however, the SaXPD protein is less similar to human XPD than the 
S. cerevisiae homolog Rad3 (19). The crystal structures of SaXPD have provided a 
wealth of information, but Rad3 at 90 kDa is much more similar in size to human XPD 
(89 kDa) than SaXPD (68 kDa).  SaXPD lacks about 200 amino acids that are found in 
ScRad3.  Additionally, yeast more closely resemble human cells and would provide 
greater insight into the biochemical activities and fundamental basis for human diseases 
caused by the XPD protein compared to the thermophilic bacteria.  Fewer techniques 
exist for genetic manipulations in S. acidocaldarius compared to the well-studied yeast S. 
cerevisiae. Many disease-relevant mutants have been explored in cellular extracts, with 
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XPD in complex with TFIIH, but few studies have explored the purified protein to verify 
its activity as native to Rad3 (9, 11, 30, 31). Here we report a new purification from E. 
coli, as well as some characterization of the G47R, I463V/del716-730 (I463V/Δ), R618P, 
R618W, and C665R mutations, which have been identified in XP-patients (7, 21, 22).  
Furthermore, we developed a haploid yeast S. cerevisiae strain to determine the in vivo 
effects associated with Rad3 mutations. To further understand their role in this disease, 
we quantitatively analyze the ATPase activity, helicase activity, DNA binding, NQO 
survival, and DNA-bound electrochemistry of these mutants.
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Figure 4.1.  Alignment of XPD-family of helicases. (Top) Sequence alignment of Homo 
sapien (human) XPD, Saccharomyces cerevisiae (sc) Rad3, and Sulfolobus 
acidocaldarius (sa) XPD.  Shown in blue boxes are the conserved cysteines that bind the 
4Fe-4S cluster, while the red arrows show mutations associated with human disease.  
(Bottom) Cartoon schematic of the Rad3 protein based on sequence alignment from 
SaXPD.  Mutations known either lead to XP, CS, TTD are shown in the boxes.  Figure 
adapted from (19). 
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Materials and Methods  
 Chemicals were purchased from Sigma Aldrich.  All reagents for DNA synthesis 
were purchased from Glen Research.  Gold-on-mica was purchased from Agilent 
Technologies.  All yeast media was purchased from Clontech. 
Protein purification 
 Plasmids harboring the appropriate copy of the Rad3 gene were transformed into 
E. coli BL21(DE3)pLysS cells (Agilent) and plated onto LB+Chlr+Amp plates.  Bacteria 
were grown in 2L batches of TB + chloramphenical (25 mg/mL) + ampicillin (100 
mg/mL) at 37°C for 5-6 hours until they reached OD600 ~ 0.6.  The temperature was 
immediately dropped to 16°C, and cells were induced with 200 µM IPTG for 20-22 
hours.  Cells were pelleted and rinsed with 1X cold PBS and stored at -80°C until used.  
 Cells were resuspended in 1% HisTrap Buffer (20 mM Tris pH 8.0, 500 mM 
NaCl, 0.5 mM immidazole) with Protease Complete tablets (1 per 50 mL buffer) (Roche) 
using a homogenizer, and cells were lysed by microfluidization.  Cleared cell lysates 
were loaded onto a pre-equilibrated HisTrap column (GE Life Sciences) and eluted by a 
linear elution gradient of 1-100% HisTrap Buffer B (20 mM Tris pH 8.0, 500 mM NaCl, 
500 mM immidazole, 0.5 mM DTT) over 6 column volumes.  Fractions were pooled and 
loaded onto a pre-equilibrated HiPrep 26/10 desalting column with 20% Anion Exchange 
Buffer (20 mm Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 2 mM DTT).  The buffer 
exchanged protein was then loaded onto a pre-equilibrated Heparin column (GE life 
sciences) and eluted by linear gradient of 20-100% Anion Exchange Buffer B (20 mM 
Tris pH 8.0 1 m NaCl, 1 mM EDTA, 2 mM DTT).  Fractions were pooled and 
concentrated using Amicon 100K MWCO filter units at 4,000 x g.  The concentrated 
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product was loaded onto a Superdex200 gel filtration column with gel filtration buffer 
(20 mM Tris pH 8.0, 500 mM NaCl, 1 mM EDTA, 2 mM DTT) and eluted.  Rad3-
containing fractions were pooled and concentrated by Amicon 100K MWCO filter units 
and buffer exchanged into protein storage buffer (20 mM Tris pH 8.0, 200 mM NaCl, 1 
mM EDTA, 5% glycerol).  Final fractions were quantified by UV-visible spectroscopy 
and stored at -80°C until needed.  The identity of the protein was confirmed by running a 
7.5% SDS-PAGE gel, Trypsin digest MS/MS (Caltech, PPMAL), and activity assays. 
Site-directed mutagenesis 
 Site-directed mutagenesis (SDM) was performed per the manufacturers 
instructions  (Agilent Technologies).  The following primers were used to generate the 
appropriate mutations in both the 7AC plasmid for protein purifications and the PRS313 
plasmids for in vivo assays (Table 3.1).  Plasmids were transformed into E. coli and 
plated onto selective media.  Individual colonies were grown and mini-prepped.  
Mutations were verified by sequencing  (Laragen Inc.). 
ATPase assay 
 ATPase activity was measured by monitoring production of free phosphate 
catalyzed by the hydrolysis of ATP using the Biomol Green Reagent (Enzo Life 
Sciences).  In a 96-well plate, 50 µL of 20 nM ssDNA, 50 µM ATP, 25 nM Rad3 was 
incubated in assay buffer (50 mM Tris pH 8.0, 0.1 mg/mL BSA, 2 mM MgCl2) for 60 
minutes at 30°C.  Reactions were quenched with 100 µL of Biomol Green Reagent, 
incubated at room temperature to allow the reagent to develop, and absorbances were 
measured using a plate reader with 630 nm filter cut-off.  ATPase activity was 
determined by comparing absorbance values against a standard curve. 
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Helicase Assay 
 Cy5-and Iowa Black Dark (IBRQ)-modified DNAs were ordered from IDT DNA 
(Coralville, IA).   
The strands used were:  5ʹ′- (Cy5) CCTCGAGGGATCCGTCCTAGCAAGC - 3ʹ′ and  
5ʹ′-GCTCGAGTCTAGACTGCAGTTGAGAGCTTGCTAGGACGGATCCCTCGAGG 
(IBRQ) -3ʹ′.  DNA was annealed in phosphate buffer (20 mM phosphate, 50 mM NaCl, 
pH 7.5).  Duplexes were quantified by UV-visible spectroscopy and diluted to reach a 
final concentration of 1µM.  Using a Bio-Rad 96-well plate fluorescent themocycler 
reader, 30 µL reactions of 5 nM duplex, 500 µM ATP, and 10-300 nM Rad3 were 
incubated in assay buffer and monitored over one hour, with scans taken every 30 
seconds.  Reactions were initiated by addition of ATP.  Helicase activity was measured 
and fit to first-order kinetics to determine rate constants. 
DNA-binding experiments 
 Fluorescence anisotropy was measured using a Flexstation 3 instrument.  Rad3-
DNA interactions were probed in a reaction mixture of assay buffer with 10 nM 
fluorescein-labeled DNA (IDT DNA) in 20 µL reactions using the substrate 
5ʹ′(fam)CACGTTGACTACCGTC -3ʹ′.  The protein-DNA mixture was incubated at 30°C 
for 20 minutes, and fluorescence was monitored at 520 nm for in 30-second intervals for 
5 minutes.  Polarization data was measured in triplicate and fit to a 4-parameter hill 
coefficient to determine ssDNA binding constants using kaleidagraph. 
S. cerevisiae Rad3 knockout generation 
 The diploid ΔRad3 knockout was obtained from the yeast knockout collection 
(Thermo Scientific).  This was transformed with the complementation plasmid containing 
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the Rad3 gene on PRS316 plasmid.  Individual colonies were sporulated and dissected.  
After performing tetrad analysis, an individual colony capable of growing in SD-URA, 
geneticin, YPD, and not in the presence of 5-fluoro-orotic acid was stored as the parent 
yeast knockout strain. 
Yeast transformations and plasmid shuffle 
 Mutations in the PRS313-based plasmids harboring the RAD3 gene were 
introduced by SDM.  The parent yeast strain was grown to an OD600 ~ 0.6 in SD-URA.  
Cells were then pelleted for 30 seconds at 8,000 RPM.  The cells were rinsed with water 
and re-suspended in 160 µL LiOAc buffer (100 mM LiOAc, 10 mM TRIS-HCl pH 7.5, 1 
mM EDTA, 1 M sorbitol) and shaken at 30°C for one hour.  Next, 2.5 µL of 10 mg/mL 
salmon sperm DNA (Sigma) was added with 4 µL of mini-prepped DNA (~100 mg/mL) 
and incubated at 30°C for 30 minutes without shaking.  400 µL of PEG buffer (40% PEG 
4000, 100 mM LiOAc, 10 mM Tris HCl, pH 7.5, 1 mM EDTA) was added and incubated 
at 30°C for 20 minutes without shaking.  Finally, yeast were heat shocked at 42°C for 5 
minutes and plated 200 µL onto selective media plates (SD –URA – HIS).  
 Individual colonies were grown in SD-URA-HIS overnight to reach saturation.  
Next, 40 µL was used to innoculate a 4-mL SD-HIS culture.  After 6-8 hours, a 4 mL 
culture of SD –HIS + FOA was inoculated and allowed to grow overnight.  The culture 
was plated onto SD-HIS plates, and colonies were verified for plasmid shuffle by testing 
growth in geneticin, YPD, SD-HIS, 5-fluoro-orotic acid, and lack of growth in SD-URA. 
Growth curves 
 All growth curves were performed in a similar fashion.  Overnight cultures were 
grown to stationary phase and used to inoculate a 4 mL culture (1/100th dilution).  
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Cultures were shaken at 200-220 rpm and grown at 30°C.  At indicated time points, an 
aliquot was removed and diluted accordingly to obtain an OD600 using a Cary UV-Visible 
spectrophotometer.   
Colony counting 
 The typhoon counts colonies through the coomasie setting in fluorescence mode, 
and colonies counted are consistent with manual counting.  Overloaded plates cannot be 
differentiated, but colony counts between 0 and 200-300 colonies are accurately counted 
with the software.  Typical software parameters are 9000, 9, 19, 500 with splitting 
colonies set to a factor of 9, giving counts consistent with the manual counts.   
UV-survival  
Briefly, an overnight culture of an individual colony was grown in SD – HIS to 
reach stationary phase.  A 2 mL culture of 1 x 107 cells/mL (OD600 = 0.6) was made and 
transferred to a small 2 mL petri dish, followed by immediate irradiation.  100 µL of the 
culture was used to create 10-fold serial dilutions, which were plated onto pre-warmed 
SD –His plates and incubated at 30°C for 72 hours in the dark, followed by imaging.  
Colonies were counted, and survival was determined based on the number of viable 
colonies. 
 Spotting assays were performed in a similar manner.  Serially diluted cultures (5 
µL) were plated onto pre-warmed SD –HIS plates and irradiated with 254 nm light.  
Images were taken after 72 hours of growth at 30°C in the dark. 
NQO-survival  
 Individual colonies were grown to saturation and serially diluted in water.  These 
were then plated on the appropriate SD-HIS + NQO plates and incubated at 30°C for 72-
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96 hours.  Once colonies were formed, they were counted.   Spotting assays were 
performed in a similar manner.  Serially diluted cultures (5µL) were plated onto pre-
warmed SD-HIS +NQO plates.  Images were taken after 72 hours of growth at 30°C in 
the dark. 
 Growth curves were obtained starting with saturated cultures, which were used to 
innoculate (100x) 4 mL of SD-HIS.  At the indicated times, anywhere from 50-400 µL of 
culture were measured using a Cary spectrophotometer to measure absorbance at 600 nm.  
These values were then plotted and fit to a 4-parameter hill equation to obtain a t1/2. 
DNA synthesis 
 DNA was synthesized as previously described.  Standard phosphoramidites were 
used on an ABI 3400 DNA synthesizer with modifications from Glen Research.  DNA 
was purified by reverse-phase HPLC and solvent removed through lyophilization.  
Disuflide modified DNA was resuspended in 400 µL reduction buffer (50 mM Tris, pH 
8.0) and reduced with 10 mg of DTT.  DNA quantification was based on UV-visible 
absorbances at 260 nm.   
DNA-modified electrochemistry 
50 µM duplex DNA was annealed in degassed phosphate buffer (50 mM 
phosphate, 100 mM NaCl, 1 mM EDTA, pH 7.5) and allowed to self-assemble on a gold-
on-mica surface overnight (Agilent technologies).  Excess DNA was washed a minimum 
of three times from the surface with phosphate buffer.  The surface was then backfilled 
with a solution of 1 µM mercaptohexanol in protein buffer (200 mM NaCl, 50 mM Tris, 
pH 8.0, 1 mM EDTA and 5% glycerol).   Protein was added to the electrode housing, and 
electrochemistry was performed using a CH Instruments 600 potentiostat and a 3-
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electrode set-up with a Ag/AgCl reference electrode, platinum auxiliary, DNA-modified 
electrode, and the working surface.  All measurements were performed in a glovebag to 
prevent degradation of the protein cluster and minimize the presence of oxygen.  
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Results 
 
Isolation of haploid S. cerevisiae with a Rad3 knockout for survival studies   
 An S. cerevisiae heterozygous diploid Rad3 knockout was obtained from the yeast 
knockout (YKO) collection (Thermo Scientific).  A plasmid encoding the Rad3 gene was 
then transformed into the diploid strain.  Successful transformations were isolated and 
grown on SD – URA – HIS, and twelve colonies were sporulated and dissected.  Each 
tetrad was plated on SD –URA, YPD, geneticin, and FOA plates.  Tetrad analysis of 
individual spores identified an individual haploid strain that had Rad3 knocked out and 
replaced by a kanamycin gene in the genome (Figure 4.2).  This was evident by a spore 
capable of growing on SD – URA, YPD, geneticin, but not on FOA plates. 
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Figure 4.2.  Tetrad analysis for generating Rad3 knockout S. cerevisiae.  Tetrad 
analysis for 12 individual sporulated colonies on either YPD, G418, FOA or URA.  “+” 
Indicates that the yeast survived, while  “-“ indicates that the yeast did not survive on the 
YPD (top right), geneticin (top middle, right), FOA (bottom middle, right), and SD –
URA (bottom, right) plates.   
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Characterization of Rad3 knockouts 
 
Based on disease-related mutations in human XPD, a series of haploid yeast 
strains have been isolated (Table 4.1), in which the only difference is the copy of Rad3 
that is maintained on the plasmid. In each strain, the gene encoding for Rad3 has been 
deleted from the genome and been replaced by a kanamycin gene (Table 4.1).  The initial 
strain of S. cerevisiae generated is complemented by WT Rad3 on a PRS316 plasmid, 
which encodes for the URA3 gene and allows for growth in SD – URA.  A plasmid 
shuffle is used to change the copy of Rad3 in the yeast strain. First, a transformation of 
the mutant Rad3 on a PRS 313 plasmid, which encodes the HIS gene, is accomplished.  
This leaves copies of both the PRS313 and the PRS316 plasmids in the cell.  By changing 
the media to SD-HIS, the PRS316 plasmid leaves the cell.   This is followed by a 
selection using SD-HIS + FOA, an auxotrophic selection that kills any strain containing 
the original PRS316 plasmid (Figure 4.4).  Individual colonies are then isolated and 
verified to have the plasmids shuffled by growing in selective medias.  If the 
transformation is successful, mutants will grow in G418 (indicating that the Rad3 gene 
has been deleted from the genome), SD-HIS (indicating the presence of PRS313), and 
SD-HIS+FOA (indicating the presence PRS 313 and absence of PRS316).  The strains 
will be incapable of growing in SD-URA (indicating absence of PRS316) as well as SD-
URA-HIS (indicating that only the PRS313 plasmid is present).   
Mutations for each Rad3 strain were introduced by site-directed mutagenesis on 
the PRS313 plasmid.   Most of the disease-relevant mutations were well conserved 
between SaXPD, ScRad3, and HsXPD, but a few mutations exist only in ScRad3 and 
HsXPD due to the complex nature of the eukaryotic proteins.  In both Sulfolobus 
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acidocaldarius and humans, the L325 (Sa) and L461 (human) correspond to I463 (Sc).  
Furthermore, in human patients, the L461V mutation is often accompanied with a 
deletion of amino acid 716-730 in the c-terminal region.  A site-directed mutagenesis 
method was used to generate the corresponding I463V/del716-730 (I463V/Δ) mutation in 
ScRad3.     
To verify that Rad3 is essential for survival, each strain was grown in both SD-
HIS and SD-HIS+FOA.  If the original WT plasmid is present, the strain will show 
reduced growth in SD-HIS+FOA.  This only occurs in strains that lack a viable copy of 
Rad3.  In this case, the cell would adapt to survive in the presence of FOA.  As shown in 
Figure 4.5, all strains grow similarly to the WT strain in both SD-HIS and SD-HIS+FOA, 
with the exception of the empty plasmid.  This indicates that all mutant copies of ScRad3 
generated are viable.   
Growth curves were performed on each strain to verify that mutations in Rad3 do 
not lead to any growth defects in vivo.  The majority of the strains grow at a rate within 
that of the WT Rad3 strain, however the R618P and the empty plasmid strains grow 
significantly slower (Figure 4.5, purple and green curves).  The empty plasmid does not 
grow as well because Rad3 is an essential gene. The growth defect in R618P suggests 
that this mutation in Rad3 significantly alters the survival characteristics of this yeast 
strain.  The strain not only grows slowly, but also reaches a lower cell density (OD600 ~ 
5.0) compared to the WT strain (OD600 = ~ 6.0).  
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Figure 4.3 PCR based SDM strategy for the deletion of regions of a plasmid.  
Forward and reverse primers were designed to delete the region in red.  Primers were 
designed to be homologous to the forward region (blue) and the tail region (green) on the 
forward primer and complementary to the orange region and black regions on the reverse 
primer. 
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Yeast Strain Rad3 Copy SaXPD Mutation 
A-1* WT L325I 
B-1 I463V L325V 
C-1 G47R G34R 
E-1 C665R A511R 
F-1 (p) -- 
G-1 I463V/M468A L325V/M331A 
H-1 I463F L325F 
I-1 I463L WT 
J-1 I463V/del716-730 L325V/del 
K-1 WT/del716-730 WT/del 
L-1 R618P R460P 
M-1 R618W R460W 
N-1 I463V/M468A/del716-730 L325V/M331A/del 
O-1 R618A R460A 
P-1 R618E R460E 
Q-1 R618L R460L 
R-1 R618Y R460Y 
Table 4.1.   Yeast strains generated with variants in Rad3 compared to SaXPD 
alignment. *Note, that in SaXPD L325 aligns with I463 in ScRad3. 
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Figure 4.4   Rad3 mutant viability by the plasmid shuffle.  (A) Cartoon Schematic for 
plasmid shuffle to isolate S. cerevisiae containing mutants of Rad3.  Briefly, WT Rad3 is 
encoded on a plasmid containing the URA3 gene into haploid yeast with Rad3 deleted 
from the genome.  Mutants of Rad3 are encoded onto a plasmid encoding the HIS gene 
and transformed into the original cells.   The media is then shifted to only SD-HIS to 
remove the original plasmid and then counter-selected in FOA to ensure the removal of 
the WT copy of Rad3.  (B) OD600 measurements of individual yeast strains grown in both 
SD-HIS and SD-HIS + FOA (normalized to WT).  The strain containing the empty 
plasmid is inviable when grown in the presence of FOA, confirming the fact that Rad3 is 
an essential gene.  All of the other individual point mutations are viable. 
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Figure 4.5.  Growth curves of Rad3 strains in SD-HIS.  Strains were monitored for 
growth by absorbance OD600.
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UV-Survival assay 
An easily-generated NER product is the cyclopyrimidine dimer (CPD), which can 
be formed by irradiating DNA at 254 nm.  Even a single CPD dimer can have disastrous 
downstream consequences (2, 3).  The yeast genome is approximately 12,000,000 base 
pairs (32).  UV damage generates approximately 6700 CPDs per 60 J/m2 of 254 nm UV-
light (33).  Based on this, we calculated the number of CPDs generated during irradiation.  
Assuming an average distribution of damage, we then determined the average distance 
between dimer sites (Figure 4.6).  Under conditions of high irradiation (200 J/m2) the 
average distance between dimers is only 700 base pairs.    
To understand how the Rad3 mutations perform in vivo in response to NER 
damage, we performed a UV-survival assay measuring survival after 200 J/m2 UV-light 
on the WT, G47R, I463L, I463V, and I463V/Δ mutant strains.  The G47R strain shows 
no noticeable growth  (Figure 4.7).  The WT Rad3 shows survival at 12.7 ± 0.7%, 
whereas a simple I463L mutation leads to a small increase in viability 19.3 ± 2.0%.  In 
contrast, when mutated to a valine, a known disease mutation in humans when combined 
with a c-terminal deletion, the strain survives only 11.2 ± 0.3% when UV-irradiated.  The 
I463V/M468A mutant, which exhibited mildly improved CT (Chapter 3), survives at 
about 14.3 ± 0.6%, better than both the WT and I463V mutant strains (Figure 4.7).  
Perhaps by generating large amounts of DNA damage we have amplified the small 
differences between these strains.   
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Figure 4.6. Calculated thymine dimer damage in yeast S. cerevisiae. Calculation 
based on 6700 thymine dimers generated per 60 J/m2 UV irradiation with a yeast genome 
of 12 million basepairs.  In red is the % of genome expected to be damaged given the 
amount of irradiation, while in green is the average distance between dimers based on the 
number of damage sites and total size of the genome.   
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Figure 4.7.  UV-survival of Rad3 strains at 200 J/m2. Survival of WT (orange), I463L 
(red), I463V (blue) and I463V/M468A (brown) yeast strains after 200 J/m2 UV dosage.  
Fraction survival is measured relative to the unchallenged samples.  Standard error is 
shown and based on the number of individual samples measured.  For p-values, * = p 
<0.05; ** = p <0.01; *** = p <0.001 
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NQO-Surivival Assay 
 4-Nitroquinoline 1-Oxide (NQO), a UV mimic that generates quinol-base adducts 
that must be repaired by NER, was used to chemically mimic the UV-survival assay, as a 
chemical damaging agent provides more control over the amount of damage the cells 
receive.  Using the WT, G47R, I463V/Δ, R618P, R618W, and C665R mutant yeast 
strains, survival was measured when grown in the presence of 20 ng/mL, 100 ng/mL, and 
200 ng/mL NQO (Figure 4.8).  The G47R, R618P, and C665R mutant strains show no 
noticeable growth at 20 ng/mL NQO.  At 200 ng/mL NQO the WT strain survives at 1.5 
± 0.38 %, while the I463V/Δand R618W strains survive at 0.23 ± 0.01 % and 0.32 ± 0.09 
%, respectively.  These mutations all show growth defects in vivo relative to the WT 
strain. 
 To investigate the kinetics of repair, growth of these mutant strains was measured 
in the presence of 20 ng/mL NQO.  When the strains are not challenged with NQO, they 
all reach log phase within 14-16 hours (Figure 4.9).  In the case of the WT, I463V/Δ and 
R618W strains a shift in t1/2 of about 1-2 hours occurs when grown in 20 ng/mL NQO.  
However, the G47R, R618P, and C665R strains show shifts of about 30 hours, indicating 
attenuated growth.  Based on alignment with the SaXPD and HsXPD proteins, these 
mutants are expected to be ATPase and helicase deficient.  Therefore, these growth 
defects are likely a result of their diminished biochemical activity.  Because all of our 
biochemical knowledge of Rad3 either comes from SaXPD or XPD cell lysates, it is 
essential to obtain the Rad3 protein to verify this biochemical deficiency. 
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Figure 4.8 NQO-survival assay of Rad3 mutants.  WT (orange), I463V/Δ, and R618W S. 
cerevisiae Rad3 mutant strains are shown.  Viable colonies were counted and compared 
to the plates lacking NQO to produce survival percentages.  The G47R, R618P, and 
C665R mutant strains show no noticeable growth. In both cases at 200 ng/mL NQO the 
mutant forms of Rad3 do not survive as well as WT.  * p <0.05
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Figure 4.9 Effect of NQO on growth for Rad3 strains.  OD600 was measured for WT 
(black), R618P (red), and R618W (blue) Rad3 mutant strains.  The dashed lines represent 
strains where NQO was added at 200 ng/mL.  In the WT and R618W strains, the t1/2 
changes from 15.1 to 18.2 hours and 14.5 to 17.0 hours, respectively, while in the case of 
R618P, this changes from 16.2 to 60 hours, suggesting that NQO plays a devastating 
effect in R618P.
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Mutations at R618 in S. cerevisiae Rad3 show variable growth in response to NQO 
 
The R618P and R618W Rad3 mutations exhibit very different growth 
phenotypes.  Recently, a cerebro-oculo-facio-skeletal syndrome patient was found to 
have an R618Q found in their XPD gene (34).  To determine how these mutation affect 
growth, we modeled various amino acid substitutions using the SaXPD crystal structure 
(Figure 4.10).  Five amino acid substitutions were made that have an effect on either 
charge, aromaticity, or sterics.  By replacing the arginine with a leucine (slightly 
hydrophic), glutamate (negatively charged), alanine (loss of side chain), or tyrosine 
(aromatic), we expected to observe variances in survival.  We hypothesized that the 
negatively charge glutamate should repel DNA binding and therefore have reduced 
viability, while the aromatic tyrosine should behave similarly to WT.   
In an NQO-survival assay (Figure 4.11), each disease-related strain shows 
attenuated growth relative to the WT strain.  The G47R, R618P, and C665R strains show 
less than 0.0001% growth on plates containing 20 ng/mL NQO.  When examining the 
mutations at R618 we found that survival is in the order of proline < glutamate < alanine 
< tryptophan < tyrosine ≈ leucine ≈ arginine (WT).   This is likely due to the large 
structural changes associated with proline, as well as the change in charge by introducing 
the negatively charged glutamate.  Alanine removes any side chain functionality, which 
presumably disrupts the protein-fold.   This residue is therefore important, as subtle 
changes drastically affect survival in these yeast strains. 
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R460P R460W 
 
 
R460Y R460A 
 
 
R460E R460L 
Figure 4.10  Pymol representations of mutations at the R460 position in SaXPD.  In 
red mesh is the original leucine, while the colored spheres represent the mutations 
indicated.  Based on the SaXPD crystal structure (PDB ID 3CRV), the analgous 
mutations were made in Rad3. 
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Figure 4.11.  NQO survival assay for WT (black), G47R (red), R618W (brown), R618P 
(brown), R618L (green), R618E (mauve), R618A (fuscia), R618Y (purple), I463V/Δ 
(blue), I463V/M468A/Δ (light blue), and C665R (gray) Rad3 strains.  Note that for 
G47R, R618P, and C665R, minimal growth was observed at 20 ng/mL. 
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Effect of Rad3 mutants in survival from non-NER DNA damaging agents 
Spot assays provide a quick and easy means for assaying viability for a variety of 
targets.  Typical substrates for NER are bulky lesions such as thymine dimers or 
quinoline adducts to guanine and adenine in the DNA.  Methyl methanesulfonate (MMS) 
methylates DNA and leads to a double strand break; camptothecin (CPT) is a natural 
product that induces a covalent crosslink between DNA and topoisomerase I.  This lesion 
must be end resected and also leads to double strand breaks and collapsed replication 
forks; hydroxyurea (HU) inhibits DNA replication and leads to stalled replication forks.  
The chemical structures of these DNA damaging agents are shown Figure 4.12.  Rad3 
may be responsible for repairing lesions not previously linked to NER.  To test the ability 
of Rad3 mutants to repair DNA damage, spot assays were performed with either CPT, 
MMS, or HU(35)  (Figure 4.12).  In the presence of HU, which inhibits DNA synthesis, 
all mutations show attenuated growth.  When grown in the presence of MMS, the G47R 
mutation shows attenuated growth.   
To observe the kinetics of repair, growth curves of the WT and G47R Rad3 
mutant strains were grown in the presence of the DNA damaging agents.  As shown in 
Figure 4.13, WT Rad3 exhibits only small changes in growth rates for NQO, MMS, and 
CPT, but shows a slower rate of growth in the presence of HU.  The ATPase/helicase 
deficient G47R mutant exhibits different growth patterns in the presence of these DNA 
damaging agents. When the G47R strain is challenged with NQO, an NER damage agent, 
t1/2 changes by over 40 hours (from 16 to 42 hours).  HU slows the growth of the G47R 
strain similarly to the WT strain, suggesting that they act similarly on stalled DNA 
replication forks.  However, when MMS or CPT were added, the G47R strain has a shift 
in t1/2 of 8 and 3 hours respectively, a result not found with the WT strain.  The change in 
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growth rate can be attributed to Rad3 assisting in the repair of these lesions.  It is highly 
likely that the helicase activity of the protein can be utilized in opening DNA around the 
sites of lesions. 
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Hydroxyurea (HU) Camptothecin (Cpt) Methyl 
methanesulfonate 
(MMS) 
4-Nitroquinoline 1-
Oxide (NQO) 
 
B. 
 
 
 
Figure 4.12.  Spot assay for Rad3 mutant strains with DNA damaging agents. A. The 
chemical structures of the DNA damaging agents.  B.  10-fold dilution spot assays for 
strains indicated on SD-HIS plates with appropriated DNA damaging agent. Images were 
taken 36 hours after plating or exposure.   
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Figure 4.13 Effect of DNA damaging agents on Rad3 mutant S. cerevisiae strains.  A.  
Serial dilutions of Rad3 mutant S. cerevisiae strains with mutations as indicated.  Each 
mutant was 10-fold diluted on SD-HIS plates with either CPT (5 µg /mL), 100 mM HU, 
or 0.007% MMS.  B.  Growth curves of WT (left) or G47R (right) Rad3 S. cerevisiae 
strain in SD-HIS (black) with 20 ng/mL NQO (blue), 100 mM HU (red), 0.007% MMS 
(yellow), or 5 µg/mL CPT (green).  Data are fitted to a 4-parameter hill equation, and t1/2 
is shown for each of the strains. 
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qPCR to monitor transcription of DNA repair genes in Rad3 mutations of S. 
cerevisiae 
Quantitative PCR (qPCR) is a powerful tool to measure transcription in an 
organism.  Briefly, mRNA transcripts are isolated from each of the strains of S. 
cerevisiae with a Rad3 mutant.  These are then reverse transcribed into cDNA to produce 
stable copies of the mRNA transcripts, which are amplified using Sybr Green Mix 
(Roche) and analyzed as previously discussed.  The genes of interest are shown in Table 
4.2, with primers listed in Appendix 1.  Genes were selected because of their interactions 
with Rad3 or their proposed role in DNA repair, especially proteins that have been shown 
to contain a [4Fe-4S] cluster such as Pol1, 2 and Pol3.  It is therefore crucial to 
understand how mutant forms of Rad3 affect regulation of the key genes involved in 
DNA repair.   
Gene transcription levels were monitored in strains with or without NQO (200 
ng/mL) for 10 minutes.  The samples were normalized to the Alg9 reference gene.  
Changes are shown as a heat map for each of the S. cerevisiae Rad3 strains (Figure 4.14).  
Isa1, Isa2 Met18, Pol2, Pol3, Rad1, and Rad3 transcription levels remain constant, even 
when challenged with NQO.  However, Pol1 and Rfc1 show increases across all strains, 
likely because Rfc1 and Pol1 are required at the initial stages of DNA repair.  Finally, the 
Rad2 gene, the XPG nuclease responsible for cleaving an NER substrate, appears to be 
up-regulated by at least a factor of 1.2 in the G47R, I463V/Δ, R618P, and WT strains.  
DNA repair genes are therefore not heavily up-regulated in response to DNA damage; in 
fact, mutant forms of Rad3 have little to no effect on these DNA repair genes. 
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Figure 4.14.  qPCR of DNA repair gens in mutant Rad3 S. cerevisae strains.  qPCR 
of genes involved in DNA repair in response to a 10 minute dose of 200 ng/mL NQO.  
(Top) Relative changes in transcription level for each of the Rad3 strains after NQO 
addition.  (Bottom) Heatmap showing trends of Pol1 and Rfc1 upregulation in Rad3 
strains, while little to no upregulation is observed when DNA damage is induced.  Up-
regulated genes are shown in green, while down-regulated genes are shown in red. 
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Gene Protein/Function 
Ssl2 XPB (helicase) 
Rad1 XPF homolog 
Rad2 XPG homolog 
Met18 MMS19 ortholog 
Rad50  
Isa1 Protein required for maturation of mitochondrial [4Fe-4S] 
proteins; functions in a complex with Isa2p and possibly 
Iba57p; isa1 deletion causes loss of mitochondrial DNA and 
respiratory deficiency; depletion reduces growth on 
nonfermentable carbon sources; functional ortholog of 
bacterial A-type ISC proteins 
Isa2 Protein required for maturation of mitochondrial [4Fe-4S] 
proteins; functions in a complex with Isa1p and possibly 
Iba57p; localizes to the mitochondrial intermembrane space, 
overexpression of ISA2 suppresses grx5 mutations 
Pol1 DNA Polymerase α 
Pol2 DNA Polymerase ε 
Pol3 DNA Polymerase δ 
Pol30 PCNA 
Rfc1 RPA component 
Act1 Actin 
Alg9 Mannosyltransferase 
Tfc1 Subunit of RNA polymerase III 
Pda1 Subunits of Pyruvate Dehydrogenase 
Rad3 XPD (helicase) 
Table 4.2.  S. cerevisiae genes involved in DNA repair.  Table summarizing the targets 
for a qPCR experiment designed to assess the changes in transcription when various 
Rad3 mutant strains are challenged with NQO (200 ng/mL).
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Isolation of S. cerevisiae Rad3 
 Our in vivo results indicate that mutations in the Rad3 protein have detrimental 
effects on viability of S. cerevisiae. While some studies describe the biochemical activity 
of Rad3 from a purified cell lysate and with purified analogous thermophilic proteins, 
few have examined the biochemical activity of mutant Rad3 proteins.  To understand the 
biochemical properties of Rad3 from S. cerevisiae, we developed a new purification of 
the protein.   Increased production of the protein was attempted by varying time, 
temperature, and IPTG amount, which is used to induce overexpression.  Small induction 
trials were performed by incubating at either 16°C, 22°C, or 37 °C.  Cells were induced 
with either 100, 200, 400, or 1000 µM IPTG, and time points were taken between 0 and 
16 hours (data not shown).  In all constructs, little to no overexpresion of ScRad3 was 
observed (Figure 4.15, cell lysate lane).  However, through a 4-column purification using 
a histrap, desalting column, heparin column, and size exclusion column, a band 
corresponding to ScRad3 was isolated.  This band elutes with a retention volume of ~120 
mLs, which is early for a protein that is 135 kDa (Figure 4.15).  This means that the 
protein may be forming aggregates or binding to other proteins as it elutes.  Aggregation 
and other protein binding increases the radius of the protein, allowing it to pass through 
the gel filtration column easily.   Minimizing interactions with other proteins and 
preventing aggregation is the next step in obtaining purified ScRad3. 
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Figure 4.15.  Representative protein purification for ScRad3 .  (Top) Flow diagram 
depicting columns attempted in this purification.  (Bottom) 7.5% SDS-PAGE gels of 
fractions indicated.  FPLC traces of fractions indicated.  Boxed area indicates pooled 
fractions. 
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Biochemical characterization of S. cerevisiae Rad3 
 Rad3 mutants were generated by using site-directed mutagenesis and isolated and 
purified from E. coli.  Mutants were characterized by UV-Vis to both verify the presence 
of a [4Fe-4S] cluster and quantify the protein.  Figure 4.16 shows a representative UV-
Vis trace of WT ScRad3.  Protein identities were verified by trypsin digest and MS/MS 
(PPMAL Caltech).  Purity was estimated by the A260/A280 ratio, which is indicative of 
nucleic acid contamination.  For all mutants, the ratio was less than unity (less than 5% 
nucleic acid contamination).  Concentrations were additionally confirmed by a BCA 
assay (Bio-Rad). 
 ATPase activity wa1s verified using a BIOMOL green assay (Enzo Life 
Sciences), which measures the production of free phosphate.  Each protein mutant was 
incubated in ATPase buffer in either the presence or absence of ssDNA in a 96-well 
plate.  The reactions were incubated at 30°C for 60 minutes and quenched with Biomol 
green reagent.  Colorimetric response was compared to a standard curve to determine the 
amount of ATP consumed.  Figure 4.17 shows ATPase activity of ScRad3, SaXPD and 
no protein immediately after Rad3 purification.  ScRad3 hydrolyzes 52% of the available 
ATP, while SaXPD hydrolyzes 89% of available ATP.  A similar ATPase assay was 
performed after generating various ScRad3 mutants.  The C665R mutant has no 
detectable ATPase activity, while the G47R, R618P, R618W, and I463V/Δ mutations 
have 38%, 29%, 57%, and 38% of WT ATPase activity, respectively.  However, each of 
the mutants has diminished ATPase activity (less than 10% of available ATP) (Figure 
4.18).       Therefore, at -80°C the protein is unstable in the storage buffer and loses 
ATPase activity. 
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Figure 4.16.  Representative UV-vis spectra of ScRad3.  Absorbance at 410 nm is used 
for quantification using ε = 17,000 M=1. 
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Figure 4.17  ATPase activity of ScRad3, SaXPD.  ATPase activity measured after 60 
minute incubation at 30°C. 
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Figure 4.18.  ATPase activity of Rad3 mutants after storage.  1 pmol Rad3 was incubated 
with 2500 pmol of ATP.  Release of free phosphate was measured with BioMol green.  
ScRad3 WT (red), G47R (blue), C665R (orange), R618P (brown), R618W (purple), 
I463V/Δ (green) mutants, and no protein (black) were incubated at 30°C for 60 minutes.  
In red is the previously shown value for WT ScRad3 (Figure 3.20). 
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Helicase activity more definitively confirms Rad3 activity compared to ATPase 
activity, as there are only a few helicases in the cell.  A fluorescent helicase assay was 
designed using a Cy5 fluorophore and Iowa Black quencher.  When the duplex is 
annealed, little to no fluorescence is observed.  However, upon unwinding of the strands 
by the helicase, the Cy5 signal is observed.  As shown in Figure 4.19, without the 
addition of protein, a negligible amount of fluorescence increase is observed.  As a 
control, a melting temperature is measured after all assays.  In the case of no unwinding 
(duplex only), a melting transition is observed at approximately 72°C.  However, when 
the substrate is fully unwound, as with Rad3 addition (black line) or ssDNA with a 
fluorophore (red curve), there is a linear decrease in fluorescence.  As a control, we also 
observed SaXPD helicase activity; as SaXPD is a thermophile, it functions at higher 
temperatures.  Minimal unwinding is observed at room temperature, but as the 
temperature is increased a new melting temperature at ~52°C is observed (Figure 4.19). 
Figure 4.1 shows helicase activity for each of the ScRad3 mutants.  Activity was 
measured as a function of fluorescence over 60 minutes. The WT, R618W, and I463V/Δ 
unwind the entire substrate, 102%, 110%, and 92.5%, respectively, while the G47R, 
C665R, and R618P show diminished helicase activity, less than 50% (Table 4.3).  This 
could be a result of protein aggregation or other proteins present that have the ability to 
unwind DNA.   
A titration was performed to determine the DNA-binding constant for ScRad3 to 
ssDNA using fluorescent DNA.  A representative titration is shown in Figure 4.20. All 
protein mutants bind with low nM affinity (Kd ~ 40-125 nM), as helicases are required to 
open duplex DNA and must bind tightly to DNA.
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Figure 4.19. Fluorescent helicase activity of Rad3 mutants.  (Top) Cartoon schematic of 
fluorescent helicase assay.  (Bottom) Time course experiments for Rad3 mutants 
incubated with the substrate shown above.  Note that only for active helicases do we 
observe activity. 
 134 
 
 
 
 
Figure 4.20.  Representative FP binding data for Rad3 to fluorophore DNA.  Protein was 
titrated and quantified over a period of 2 minutes.  The FP data was fit to a 4-paramenter 
hill equation to obtain a binding constant to ssDNA. 
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S. cerevisiae Rad3 S. acidocaldarius XPD(19) 
Mutation ATPase 
activity 
[mol/sec] 
Helicase 
activity [% 
unwound] 
ssDNA Kd 
[nM] 
Mutation ATPase 
activity 
[mol/sec] 
Helicase 
activity 
[bp/min] 
ssDNA 
Kd 
[nM] 
WT 0.039  
(100%) 
102 ± 1.5 80 ± 7 WT 1.24 ± 
0.03 
20.5 ± 0.7 66 ± 55 
G47R 0.016  
(38%) 
50.2 ± 0.7 
(49%) 
109 ± 27 G34R 0 ± 0.01 
(0%) 
0.83 ± 0.1 
(4%) 
67 ± 10 
C665R N.D. 70.6 ± 0.8 
(69%) 
125 ± 51 A511R N.D. N.D. 62 
R618P 0.011 (29%) 50.9 ± 1.33 
(50%) 
68 ± 13 R460P 0.028 ± 
0.0004 
(2%) 
2.78 ± 0.1 
(14%) 
79 ± 3 
R618W 0.021 (53%) 110 ± 2.3 
(108%) 
100 ± 10 R460W 0.66 ± 
0.03 
(53%) 
19 ± 4.3 
(93%) 
67 ± 10 
I463V/Δ 0.016 (38%) 92.5 ± 1 
(91%) 
48 ± 6 L325V 1.24 ± 
0.03 
(100%) 
20.5 ± 0.7 
(100%) 
69 ± 8 
Table 4.3.  Relative biochemical activities of ScRad3 and SaXPD.  In parentheses is 
activity relative to WT. 
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Electrochemical Characterization of Rad3 on DNA-modified electrodes  
 A major unexplored area of research for [4Fe-4S] cluster-containing proteins is 
their redox activity when bound to DNA. We interrogated the ability of the Rad3 protein 
to perform DNA-mediated redox chemistry. Using a DNA-modified electrode (Figure 
4.22), known concentrations of Rad3 based on 410 nm absorbance were incubated and 
currents were measured.  S. cerevisiae Rad3 exhibits a reversible redox-active signal with 
a midpoint potential of 90 mV vs. NHE, consistent with previously-studied DNA repair 
proteins.  As the protein was incubated on the surface, the redox signal increased linearly 
with time, suggesting that this process is slow and likely diffusion-limited.  The signal is, 
in fact, diffusion limited, as evidenced by the linear relationship between the midpoint 
redox potential and the square root of scan rate, consistent with the previously studied 
proteins in our lab.  This signal is reversible, with a ratio of ipc/ipa = 1 for scan rates of 
10-200 mV/sec (Figure 4.21).  Together, these data indicate that the redox signal 
observed from Rad3 on a DNA-modified electrode is DNA-mediated and identical to the 
previously studied BER and NER proteins. 
 To assay the CT proficiency of the Rad3 mutants, each mutant was incubated on a 
DNA-modified electrode for 90 minutes.  CVs were taken every 3 minutes, and currents 
were measured from the reductive sweep.  As shown in Figure 25, all of the proteins have 
a redox proficiency similar to that of the WT protein, at approximately ~90 mV versus 
NHE.  The G47R mutant, which is helicase and ATPase deficient, has a relative current 
intensity (1.26 ± 0.07) similar to that of the WT protein, suggesting that its role in disease 
is a direct result of its inability to perform basic biochemical functions.  Our other 
mutants, C665R, R618P, and R618W, have redox signals that are 0.82 ± 0.04, 0.86 ± 
0.06, and 0.76 ± 0.07 respectively, which are comparable to that of the WT protein.  
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These signals are much smaller than previously reported proteins, likely due to the 
impurities associated with protein purification.  In particular, the formation of aggregates 
as well as other binding partners could be the cause of this problem and should be further 
optimized. 
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Figure 4.21.  Electrochemistry of Rad3 protein on a 5ʹ′ ssDNA overhang DNA-modified 
electrode. (Left) plot of current versus scan rate and square root of scan rate.  The linear 
relationship suggests that this process is diffusion limited, consistent with previous 
reports for [4Fe-4S] cluster-containing proteins.  (Right) Plot of ipa/ipc, showing that this 
reaction is fully reversible over the scan rates presented. 
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Figure 4.22.  Electrochemistry of Rad3 proteins.  A. Background corrected CV of WT 
Rad3 protein. B. Relative current intensity for protein mutants compared to WT Rad3. 
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Discussion 
The XPD family of helicases is essential for nucleotide excision repair (NER).  
These proteins are well conserved between species, and mutations found in S. 
acidocaldarius XPD are also found in human XPD.  Many mutations that lead to XP-
related diseases are found in the thermophilic SaXPD, which is a difficult organism to 
work with and not an ideal model for human XPD.  Conversely, the model organism S. 
cerevisiae has been extensively studied, and a host of biomolecular tools exist for genetic 
manipulation.  Rad3 is the yeast homologue of SaXPD and HsXPD, and most of our 
understanding of the protein is from cellular extracts and early studies of the protein.  
Besides being a more direct homologue, S. cerevisiae cells more closely mimic human 
cells and provide an excellent model for direct comparisons. Obtaining this protein 
enables the determination of the effect these disease-related mutations have 
biochemically, which explains their role in disease.   
Rad3 was expressed and purified in E. coli and found to contain a redox active 
[4Fe-4S] cluster.  No overexpression was observed, however purification of the MBP-
tagged Rad3 was achieved through a combination of four columns to yield 2 mg/mL 
protein.  XPD-conserved Rad3 protein mutants were generated.  These G47R, I463V/Δ, 
R618P, R618W and C665R mutations all contain [4Fe-4S] clusters, as monitored by UV-
visible spectroscopy.  DNA binding constants show that the protein binds ssDNA in the 
range of 40 – 125 nM, consistent with the previously-purified SaXPD protein. Initial 
ATPase and helicase activities follow similar trends to previously reported SaXPD 
activities, but must be confirmed, as protein stability in the storage buffer appears to be 
questionable.    
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 Saccharomyces cerevisiae more closely resembles human cell lines than the 
archaeal S. acidocaldarius; we have developed a Rad3 knockout strain that allows for 
easy manipulation of the copy of Rad3 by taking advantage of a plasmid shuffle.  Both an 
NQO- and UV-survival assay were developed to measure how NER damage affects Rad3 
mutant strain growth.  In both cases, the mutant Rad3 strains survived less than the WT 
Rad3 strain, but to varying degrees.  We observed the helicase and ATPase deficient 
(based on SaXPD biochemistry) G47R, C665R and R618P mutants’ inability to survive 
when challenged with both NQO and UV-light, presumably due to their inability to repair 
the damaged DNA.  For each of these survival assays, we only saw major differences 
between the strains when using high dosages of DNA damage (200 J/m2 and 200 ng/mL 
NQO).  Perhaps by overwhelming the cell, deficiencies in each of the Rad3 mutants were 
accentuated. 
The R618W disease-related mutant, which has helicase activity, exhibited only a 
mild sensitivity to these DNA damaging agents, suggesting that helicase activity is 
essential for survival.  Over time, R618W showed repair on the order of WT strain, 
evidenced by a shift in t1/2 of only 2 hours when challenged with 20 ng/mL NQO.  
However, the R618P mutant strain showed an erratic shift of nearly 45 hours, 
demonstrating that the R618P protein is not only slower to repair but also inviable over 
the time-course of the survival assay.  Mutations were made at this position and found to 
survive in the order of proline < glutamate < alanine < tryptophan < tyrosine ≈ leucine ≈ 
arginine (WT) in an NQO-survival assay.  Substitution with aromatic residues such as 
tryptophan and tyrosine yield mutants that maintain survival, while substitution with 
destabilizing residues such as proline and glutamate yield inviable strains.  Mutations at 
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this position are found in a variety of patients, including a R618Q mutation found in a 
recently diagnosed patient (36).  This residue may play an important role in defining the 
disease state. 
   Previous reports involving the organism S. pombe suggest that the I463V/Δ 
mutation in Rad15, the equivalent of XPD, is lethal (22).  This mutation is also found in 
human patients.   However, in our model system, we observed viability closely 
mimicking the WT strain, suggesting that not all mutations are conserved between the 
model organisms.  This mutant preliminarily is both helicase and ATPase proficient and 
is not a causative mutation in the human disease.  While this mutant has been identified 
in XP-patients, it likely only leads to the disease when coupled with additional mutations. 
 Using Rad3 mutant strains, we observed how mutations in this protein affect 
growth rates and survival in vivo when the S. cerevisiae strains are challenged with a 
variety of DNA damage agents not traditionally associated with NER.  The 
ATPase/helicase deficient G47R mutation shows a much slower growth rate in the 
presence of MMS and CPT, while no such change occurs with the WT strain, suggesting 
a role in DNA repair for Rad3 beyond that of the traditional NER substrates.  The role of 
the Rad3 helicase likely extends beyond to stalled DNA replication forks as well with 
methylated DNA.  Both of these substrates are important for cellular survival, suggesting 
a significant role for Rad3 in DNA repair. 
 Finally, in an attempt to observe how mutations in Rad3 regulate DNA repair 
genes, qPCR was performed to monitor 12 unique genes.  When challenged with 200 
ng/mL NQO, no strain-specific up-regulation of the polymerases, NER nucleases, 
MMS19 orthologues, or FeS cluster machinery loading proteins is observed.  However, 
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Rfc1 and Pol1 are up-regulated in most strains, suggesting an important role for re-
starting DNA synthesis.  This appears to be a general trend and not specific to mutations 
in Rad3. 
 Obtaining pure ScRad3 further allowed us to monitor the DNA-mediated redox 
chemistry of the [4Fe-4S] cluster. When using a DNA-modified electrode with a 5ʹ′ 
ssDNA overhang, we observed a reversible midpoint redox potential of ~85 mV versus 
NHE for each of the protein mutants.  None of these proteins showed a shift in their 
redox potential; mutants were also incubated on these electrodes and, when normalized 
for cluster content, exhibited redox signals comparable to one another.  This redox 
signaling is extremely useful for signaling between DNA repair proteins, and could 
potentially be a mechanism through which Rad3 communicates with other DNA repair 
proteins. 
We have described the rapid purification and characterization of the 
Saccharomyces cerevisiae Rad3 protein from E. coli.  Rad3, the XPD homologue of S. 
cerevisiae, is responsible for repairing bulky DNA adducts through the NER pathway.  
The G47R, R618P, and C665R mutations that are responsible for disease in humans are 
confirmed to be inviable in our yeast strains when challenged with the DNA damaging 
agent NQO.  We have also studied the mutant R618W, which leads to a helicase active 
but ATPase deficient Rad3 that is still viable, albeit with a 10-fold decrease in viability 
when challenged with 200 ng/mL NQO.  The I463V/Δ mutation, which leads to disease 
in humans and inviability in the yeast organism S. pombe, is viable in our assays and 
exhibits survival comparable to the WT Rad3 strain.  We explored the effect of mutations 
at R618, which suggest that strongly destabilizing mutations lead to inviability, while 
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aromatic changes are viable in the presence of DNA damage. We also observed the 
DNA-bound redox potential of each of the protein mutants, something that is unique to 
[4Fe-4S] cluster-containing proteins.  Each of the proteins exhibits a similar DNA-bound 
potential.  Obtaining purified Rad3 enabled quick and efficient characterization of 
mutants that are believed to be involved in XP-related disease and allows for a strict 
characterization of the protein.  Future work will involve determining optimal protein 
storage conditions, characterizing the protein, and understanding the electrochemistry in 
ScRad3. However, our in vivo system enables easy manipulation of Rad3 in a haploid S. 
cerevisiae strain to better understand how Rad3 mutations affect survival and growth 
rates.  We observed that mutants of Rad3 are sensitive to MMS and CPT, two DNA 
damaging agents not previously thought of in NER.  Finally, redox signaling by Rad3 
may serve as a unique tool for DNA repair proteins to communicate with each other, as 
do other proteins implicated in DNA repair, such as the polymerases, primase, and FancJ, 
which have been shown to contain [4Fe-4S] clusters (37-42).   
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Introduction 
  Proteins involved in cellular repair pathways are charged with finding and 
correcting genomic lesions arising from a variety of sources including oxidative stress, 
UV radiation, and environmental mutagens (1). Specific repair proteins are allocated to 
target different types of DNA damage for a concerted attack. For example, the nucleotide 
excision repair (NER) pathway includes proteins that repair lesions that largely distort the 
helical structure of DNA in a variety of ways; dipyrimidine adducts and cis-platin 
crosslinks are two structurally distinct examples. In contrast, different base excision 
repair (BER) glycosylases remove specific base lesions; in Escherichia coli, for example, 
Endonuclease III (EndoIII) targets oxidized pyrimidines, while MutY repairs oxo-
guanine-adenine mismatches (1-4).  
As DNA facilitates charge transport (CT) over long molecular distances (5,6), and 
this charge transport chemistry is sensitive to a variety of lesions that perturb DNA base 
stacking (7, 8), our laboratory has proposed that repair proteins exploit this unique 
property of DNA to search for damage (9-11). Several DNA repair proteins contain 
redox-active [4Fe-4S] clusters that are not required for folding (12, 13), and examples of 
these proteins from the BER pathway, EndoIII and MutY, are activated toward oxidation 
as they bind DNA (14-16). While EndoIII effectively removes oxidized pyrimidines, the 
repair protein is found in very low copy number in E. coli (~500 copies per cell) (17, 18).  
Surprisingly, MutY, which removes adenine from 8-oxo-G:A mismatches, is found in 
even lower copy number, only ~30 copies per cell (19), which, along with the low 
selectivity of these proteins for their substrates relative to unmodified DNA, begs the 
question of how they can so effectively find and repair their target lesions in the genome. 
 153 
Importantly, mutations in the human MutY homolog (hMYH) directly correlate to the 
development of colorectal cancer (20, 21).  
We have recently examined whether DNA CT may play some role in how these 
BER proteins find their site (22, 23). Using DNA electrochemistry and AFM 
experiments, we have found that the ability of EndoIII mutants to localize in the vicinity 
of a base mismatch correlates with their ability to carry out DNA CT. Moreover, using a 
genetics assay, we found that EndoIII cooperates with MutY in vivo in finding MutY 
lesions, but that a CT-deficient mutant of EndoIII cannot similarly aid MutY (22). 
Interestingly, more proteins involved in genome maintenance are being found to contain 
[4Fe-4S] clusters, many with no clear structural or enzymatic role for the clusters. One 
such protein is XPD, which is part of the transcription factor IIH (TFIIH) machinery and 
is involved in nucleotide excision repair (NER) (24, 25). Here we consider if XPD, which 
is not involved in BER, similarly utilizes DNA CT to localize in the vicinity of lesions, 
and whether signaling between different DNA-binding proteins can occur to coordinate 
the search for damage (26, 27).  
XPD, an ATP-dependent 5ʹ′-3ʹ′ helicase from the NER pathway, is a major 
component of TFIIH, the transcriptional and repair machinery that unwinds damaged 
DNA for lesion repair in NER (28, 29). Mutations in the human XPD helicase gene 
(ERCC2) lead to the genetic disorders trichothiodystrophy (TTD), Cockayne syndrome 
(CS), and xeroderma pigmentosum (XP) (28-31). There is now evidence that mutations 
specifically in the iron-sulfur cluster domain of XPD result in TFIIH instability, leading 
to TTD (28, 30). Similarly, mutations in the analogous region of the related FancJ gene 
(which also encodes a helicase with an iron-sulfur cluster) causes predisposition to early-
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onset breast cancer (25, 32). We have demonstrated that the [4Fe-4S] cluster in 
Sulfolobus acidocaldarius (Sa)XPD is redox-active, with a redox potential equivalent to 
that of BER proteins EndoIII and MutY (~80 mV vs. NHE) (33). Moreover, as we 
describe here, a mutant of SaXPD, L325V (L461 in human XPD) is unable to mediate 
DNA CT electrochemically. Importantly, L325V aligns with mutated residues in human 
XPD and Schizosaccharomyces pombe Rad15 that lead to TTD, XP, and XP/CS (25, 31, 
34).  
Here we explore by AFM whether XPD can participate in DNA-mediated 
signaling to localize in the vicinity of a DNA mismatch.  Similar to base lesions, a single 
base mismatch inhibits DNA CT but, importantly, is not a substrate for repair by XPD 
(35).  In our model for a search facilitated by DNA CT (Figure 5.1), the search for DNA 
damage is initiated under oxidative stress by the one-electron oxidation of a DNA-bound 
protein by a guanine radical, taking the cluster from a 2+ oxidation state to a 3+ oxidation 
state. But it is DNA CT between two repair proteins that leads to the redistribution in the 
vicinity of a lesion.  With a DNA-bound potential shifted negative as compared to free 
protein (14), the proteins are expected to have a lower affinity for DNA in their reduced 
form. Thus, DNA-mediated reduction of one protein by the other leads to the dissociation 
of the reduced protein from DNA, effectively giving overall dissociation of repair 
proteins away from a region of the genome without lesions. Our model relies on the 
sensitivity of CT to proper π-stacking of the bases between the donor protein and the 
distant acceptor protein (22, 23); if, instead, there is an intervening lesion, DNA-mediated 
CT does not occur, and the repair protein remains bound and can processively move to 
the lesion and carry out enzymatic repair.  In this process, the repair proteins eventually 
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relocalize in the vicinity of lesions or any modification that inhibits DNA CT. As a result 
the overall search regime for the repair proteins is made smaller than the full genome: 
they preferentially localize where needed for repair. 
Despite various studies of EndoIII and MutY independently, it still remains to be 
established whether these proteins from different repair pathways (NER and BER) 
cooperate with one another in a coordinated search. Since a C:A mismatch, for example, 
does not distort the DNA helix, it would be expected to evade the biological NER 
pathway. Alternatively, if enzymes rely on DNA/protein CT as a first step in finding 
damage, then any protein that can carry out DNA CT can participate in the search, 
integrating repair pathways that were previously thought to be separate. To examine this 
coordinated search, AFM is used to visualize mixtures containing two types of proteins: 
i) those that are able to carry out DNA CT and ii) those that are defective at DNA CT. 
AFM, a technique that allows for visualization of single-molecule protein/DNA 
interactions, can be used to observe proteins bound to long strands (3.8 kbp) of DNA 
containing a site-specific mismatch (C:A) (23, 36-39).  Binding density ratios calculated 
from counting strands and proteins in AFM images can then give us clues to the first step 
in lesion detection. Here, not only do we examine whether proteins from the NER 
pathway redistribute in the vicinity of lesions as a function of their ability to perform 
DNA CT, but also whether they can cooperate with other repair proteins in the DNA-
mediated search for damage.  
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Figure 5.1. Model for damage detection and redistribution by repair proteins. (Top) 
Given two repair proteins of similar potential containing [4Fe-4S] clusters, which can 
carry out DNA CT, (XPD or EndoIII (blue)), CT can proceed through well-matched 
unmodified DNA. Stimulated through protein oxidation by guanine radicals (yellow) 
formed under oxidative stress, DNA CT occurs between DNA-bound proteins, promoting 
the dissociation of reduced protein (light blue). DNA CT does not occur, however, in the 
presence of an intervening mismatch or lesion (red X); repair proteins are not reduced, do 
not dissociate, and instead remain bound in the vicinity of the lesion. (Bottom) If repair 
proteins are mutants such as XPD L325V or EndoIII Y82A (red) and are unable to 
perform DNA CT (dashed line), they cannot send or receive signals to locate damage. In 
the presence of a lesion, these proteins then do not preferentially redistribute in the 
vicinity of the mismatch.  
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MATERIALS AND METHODS  
All chemicals were purchased from Sigma Aldrich.  All enzymes were purchased from 
New England Biolabs unless otherwise specified. Mica surfaces were purchased from SPI 
supplies.  Silicon AFM probes were purchased from Budget Sensors. Oligonucleotides 
were purchased from IDT or synthesized on a 3400 DNA synthesizer (Applied 
Biosystems). 
 
Mismatched (C:A) Strand Synthesis 
Four primers with the following sequences were synthesized using standard 
phosphoramidite chemistry:  
1) 5ʹ′-GTACAGAGTTCAGTCGGCATCCGCTTACAGACAAGC-3ʹ′ (forward),  
2) 5ʹ′-CCGGTAACTATCGTCTTGAGTCC-3ʹ′ (reverse),  
3) 5ʹ′-GACTGAACTCTGTACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward),  
4) 5ʹ′-GACTGAACTCTATACCTGGCACGACAGGTTTCCCG-3ʹ′ (forward) 
The underlined bases highlight the location of a 2ʹ′-O-methyl residue (Glen 
Research). Primers were phosphorylated using 5 U PNK, 10% PNK buffer, 0.5 mM ATP 
for 5 hours at 37 °C.  Primers were purified using phenol-chloroform extraction followed 
by ethanol precipitation (54). After being dried in vacuo, primers were redissolved in 20 
µL water and used in separate PCR reactions (41) using pUC19 as a template to generate 
two duplexes 1610 bp and 2157 bp (matched), each containing one 14-nucleotide single-
strand overhang. Each 100 µL PCR reaction contained 50 pmol of each of two primers, 
1X Taq buffer (100 mM Tris-HCl, 15 mM MgCl2, 500 mM KCl, pH 8.3), 0.2 mM each 
dNTP, 1 ng plasmid template pUC19 and 3 U Taq polymerase (Roche).  A typical step 
program for PCR was as follows: After incubation at 94°C for 10 minutes, 34 cycles 
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were performed as follows: 94°C for 1 minute, (52°C for primers 1+2, 54°C for primers 
2+3 or 2+4), for 1 minute, and 72°C for 3 minutes. The PCR product was then suspended 
in 50 mM NaCl/ 5mM phosphate buffer and quantitated. Separate duplexes were 
annealed at 65 °C for 8 minutes in 10 mM Tris buffer, then cooled to 20 °C during 2 
hours. A total of 15 units of T4 DNA ligase and 10% T4 ligase buffer were added (total 
reaction volume ~20 µL) and incubated overnight at 16 °C, followed by deactivation for 
10 minutes at 65 °C to yield the 3767 bp (mismatched) long strand. We did not bring the 
ligation reaction to completion, so as to obtain a mixture of DNA samples that were 
equivalent other than the presence of the mismatch at the ligation site. The DNA 
duplexes (ligated and unligated) were then analyzed by 0.6% agarose gel electrophoresis. 
Single DNA strands complementary to short duplex overhangs were ordered from IDT: 
5ʹ′-GACTGAACTCTGTAC-3ʹ′ Tm=41.6 ° C (1.6 kbp duplex overhang), 5ʹ′-
GTACAGAGTTCAGTC-3ʹ′ Tm=41.6 ° C (2.2 kbp matched duplex overhang), and 5ʹ′-
GTATAGAGTTCAGTC-3ʹ′ Tm=37.5 ° C (2.2 kbp mismatched duplex overhang). 
Single-strand DNA was purified using reversed-phased HPLC and verified with MALDI-
TOF mass spectrometry.   
Protein Purification and Expression 
EndoIII and Y82A EndoIII were expressed from the pNTH10 expression vector and 
purified as described previously (22).  EndoIII and Y82A were stored in 20 mM sodium 
phosphate pH 7.5, 100 mM NaCl, 20% glycerol, and 0.5 mM EDTA buffer. Protein 
concentrations were determined using the UV-visible absorbance of the [4Fe4S] cluster 
(410 nm, e = 17,000) (55). XPD was made according procedures described in reference 
33. 
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AFM Experiments 
AFM experiments were performed using the protocol similar to that reported previously 
(23). Stock DNA solution contained 50 –200 ng of total DNA (~6 µM) composed of the 
mixture of ligated 3.8-kbp duplexes and the two unligated duplexes (1.6 and 2.2 kb) in 6 
mM MgCl2/Tris-EDTA buffer. The 1.6 kb overhang complement (60 µM) was added to 
the DNA solution to block the 14 bp single-strand overhangs generated by PCR. This was 
then incubated overnight at 4 °C. XPD protein was dialyzed against the protein buffer (20 
mM phosphate, 100 mM NaCl, 1 mM EDTA, 5% glycerol, pH 7.5 and filtered prior to 
use) to remove residual DTT.  The concentration of individual proteins was determined 
by UV/visible spectrophotometry (Beckman DU 7400) using ε=17,000 M-1 at 410 nM for 
the [4Fe-4S] cluster.  After addition of excess 2.2 kb duplex complement (60 µM), XPD 
(0.6 µM) was added to the stock DNA solution, this protein/DNA solution was incubated 
at 4 °C overnight. A sample was then deposited (5-10 µL) onto a freshly cleaved mica 
surface for 1-2 min, rinsed with 2 mL of water, and dried under argon. Mutant XPD 
protein (L325V) was added to a stock solution of 50 ng DNA for a final protein 
concentration of 0.6 µM. Deposition conditions were identical to that for WT XPD- DNA 
samples after incubation at 4 °C overnight.  
For mixed protein experiments (WTXPD/WTEndoIII, WTXPD/Y82AEndoIII, 
WTEndoIII/L325VXPD, and WTXPD/L325VXPD), XPD, EndoIII, L325V, or Y82A was added 
to the prepared DNA solution described previously at equimolar (1:1) concentrations (0.3 
µM each) prior to incubation at 4 °C overnight. Protein/DNA complexes were formed 
with DNA solution containing ~200 ng of the mixture of PCR products and overhang 
complements (~6 µM DNA) in 6 mM MgCl2 /Tris-EDTA buffer at 4°C overnight. The 
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reaction mixture was then deposited (5-10 µL) on the mica surface for 1-2 minutes, 
rinsed with 2 mL water, and dried under argon.  
AFM Instrumentation 
Silicon AFM Probes purchased from Budget Sensors, with a spring constant of 3 N/m 
and a resonance frequency of 75 kHz, were used in a Digital Instruments Multimode 
SPM. Images were captured in air with scan areas of 2x2 µm2 or 3x3 µm2 in tapping 
mode, at an amplitude of 0.54-2.00 V and at a scan rate of 3.05 Hz.  Scan rates of 3.05 Hz 
were used in order to obtain images of higher quality.  
Binding Density Ratio Calculations 
WSxM software was used to measure general DNA contour lengths and height profiles of 
the proteins as described previously (23, 56). For each data set, images from at least three 
independent samples were analyzed, compared, and pooled (>200 long or short strands). 
Distinguishable strands and protein positions were counted by hand. The binding density 
ratio, r, is defined as the ratio of the proteins bound on long strands divided by proteins 
bound on short strands. The ratio is normalized for length by dividing by 1.9 kbp, which 
is the average length of the short strands. Binding affinities were found by determining 
the number of proteins bound per kilobasepair strand. The uncertainty was determined 
through the total number of proteins observed. 
Protein Electrochemistry 
Protein electrochemistry was performed as previously described (33).  Briefly, individual 
proteins samples were dialyzed to remove residual DTT and quantified based on 410 nm 
absorbance.  Protein was then added to a DNA modified electrode containing a 9 
nucleotide 5ʹ′ single-strand overhang.  Cyclic Voltammograms were then obtained using 
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Ag/AgCl reference electrodes and a Pt auxiliary electrode at 50 mV/s scan rate on a CH 
Instruments 620C electrochemical analyzer.   
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RESULTS 
Experimental strategy using AFM to probe protein distribution   
With BER proteins we have previously demonstrated that the ability of a protein 
to perform DNA CT directly correlates to its redistribution in the vicinity of base lesions 
or mismatches that inhibit CT (23). We tested XPD redistribution promoted through 
DNA CT by preparing DNA strands containing a single C:A mismatch, a modification 
that we know to inhibit CT (40), alongside DNA strands containing no mismatches. To 
distinguish the strands in microscopy experiments, we made mismatched strands >1200 
base pairs longer than the matched strands. AFM was utilized to gather images of DNA 
and bound protein that could be analyzed for the propensity of XPD to redistribute. ATP 
was not incorporated in AFM experiments, as XPD helicase activity should not be 
required for a DNA-mediated redistribution.  
Long (3.8 kilobase) DNA duplexes containing a site-specific C:A mismatch and 
short (2.2 and 1.6 kilobases) well-matched duplexes of the same total sequence were 
constructed. To prepare these DNA samples, pUC19 plasmid was amplified with primers 
incorporating a 2ʹ′ O-methyl residue to yield two short duplexes containing 14-nucleotide 
single-strand overhangs (23, 41). Upon ligation of these two duplexes, 3.8 kbp strands 
were formed that contained only one C:A mismatch in the middle of the strand. The 
ligation reaction was not taken to completion, so as to have a mixture of well-matched 
short and mismatched long strands for protein distribution studies. Although a C:A 
mismatch effectively inhibits DNA CT (40), it is not a lesion that is preferentially bound 
by XPD. However, the 14-nucleotide overhangs generated with PCR are specific 
substrates for XPD helicase (Kd~1 µM) (25, 42). We directly observed this preference in 
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initial AFM experiments.  Protein assignments were verified through analysis of their 3-4 
nm heights in the images; without protein, features of this dimension were not observed 
and larger heights (> 7 nm) indicated salt precipitates or protein aggregation. Only 
clearly-identifiable long or short strands and bound proteins were counted. XPD protein 
position was determined based on the distance of the protein from the end of the strand.  
We examined distribution with and without blocking the ends of short strands, 
given that XPD has some preference for single-strand overhangs. Comparing raw protein 
position (middle versus ends) on long and short strands, XPD exhibited a large preference 
for the ends (~300 bp range) of short duplexes containing overhangs (>50% of bound 
proteins). To block XPD from binding to the 14 bp segment, overhang complements were 
added to DNA/protein solutions in excess. When the overhangs were blocked, no 
preferential binding to the short strands was observed (vide infra). 
Detection of XPD Complexes 
AFM images of DNA-bound protein complexes are represented in Figure 5.2. 
XPD protein bound to matched DNA (Figure 5.2 top) can be easily distinguished based 
on strand height profile of tapping mode images. Zoomed in images display clearly 
identifiable long and short strands with protein bound (Figure 5.2 bottom). Images of 
DNA and protein complexes were acquired with a scan size of 2 x 2 µm2 or 3 x 3 µm2 at a 
scan rate of 3.05 Hz. As AFM images vary with surface cleavage, sample wetness, 
deposition time, and volume, >200 long or short strands were counted for at least three 
independent samples. The uncertainty was based on the total number of proteins counted.  
Importantly, we measured the relative binding affinity of mutants and wild type (WT) 
proteins, and, in all of the samples described, the number of proteins bound per base pair 
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remained constant (Table 5.1). Thus, any changes we saw in distribution are not due to 
differences in binding affinities of proteins. 
To probe the DNA CT properties of a redox-active DNA helicase, XPD and DNA 
complexes were examined with AFM. XPD shows redistribution onto long mismatched 
strands with a ratio of protein binding densities, r (long/short) of 1.54 ± 0.08 (Figure 5.3). 
We observed 0.23 proteins per kilobase of long strand and 0.15 proteins per kilobase of 
short strand (see Table 5.1 for further details). If we instead examine XPD distribution 
when long and short strands are fully matched, we see a binding density ratio of 0.94 ± 
0.05. Previously, for EndoIII, we found r for (long/short) was 1.6 ± 0.09 (22). We expect 
a ratio of 1 if there is an equal distribution of proteins on matched and mismatched 
strands (22). Thus, similar to EndoIII distribution, XPD, an NER protein with DNA-
bound redox-activity, redistributes to localize in the vicinity of a C:A mismatch.   
We also tested the possible redistribution of a CT-deficient mutant, L325V. The 
L325V XPD mutant exhibits an electrochemical signal that is less than half that of WT 
XPD (Figure 5.3), indicating its DNA CT deficiency. Interestingly, there is no preference 
for the mismatched strands; L325V exhibits a protein binding density ratio, r (long/short) 
of 1.14 ± 0.06 in mismatched samples, which is within error of the fully matched binding 
density ratio r (long/short) of 1.05 ± 0.07 (Figure 5.3). Thus, as with the CT-deficient 
EndoIII mutant Y82A (22), we find a correlation between the inability of L325V to 
perform CT and its lack of redistribution onto mismatched strands. Notably, even though 
the [4Fe-4S] cluster is intact, this mutant protein cannot cooperate with other proteins 
using DNA CT. This result identifies L325 as an important residue in DNA/protein CT. 
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Atomic Force Microscopy of Protein Mixtures  
We have established that DNA-mediated CT occurs on a much faster timescale 
than protein diffusion (43, 44), and we have characterized several mutants of EndoIII 
from the BER repair pathway that exhibit similar midpoint potentials of ~80 (±30) mV 
vs. NHE yet differ in their ability to carry out DNA CT (14, 23, 26). We have not yet 
provided evidence that different proteins can signal one another through DNA-mediated 
CT.  AFM provides an opportunity to examine this by assaying protein mixtures.   
WT XPD and EndoIII, both proficient at DNA CT, were mixed in a 1:1 equimolar 
ratio with DNA. Short duplex overhangs were blocked with excess complementary single 
strands. Figure 4 shows representative images of fully matched DNA strands or 
mismatched DNA strands incubated overnight with XPD/EndoIII 1:1 protein 
(WTXPD/WTEndoIII). XPD is twice as large as EndoIII (65 and 32 kDa respectively) (PDB 
IDs: 3CRV, 1P59). The average height of the protein in AFM studies can be estimated 
using the equation: R=0.717(M)1/3 where R is the radius of the protein globule in Å and 
M is the mass of the protein in Da (45). Thus, XPD is expected to have a height of 5.6 
nm, which is within error of EndoIII (4.6 nm).  While we generally cannot distinguish 
them, select images (Figure 5.4 inset) are suggestive of both EndoIII and XPD binding. 
XPD (0.3 µM)/EndoIII (0.3 µM) 1:1 protein mixture shows that XPD and EndoIII 
redistribute onto long mismatched strands with a binding density ratio r (long/short) of 
1.75 ± 0.13. Fully matched controls yield a binding ratio r (long/short) of 1.02 ± 0.07. 
Importantly, controls were also performed with only XPD (0.3 µM) under the same 
conditions. Consistent with XPD at a higher concentration (0.6 µM), XPD at half the 
concentration (0.3 µM) redistributes onto long mismatched strands (r=1.38 ± 0.07) with 
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no redistribution in fully matched samples (r=1.08 ± 0.07).  Significantly, mixing XPD 
and EndoIII protein results in a binding density ratio of 1.75, which is higher than that of 
each protein separately. This suggests that these two proteins signal one another to 
localize in the vicinity of the lesion. 
To explore cooperativity between XPD and EndoIII, we replaced WT EndoIII 
with mutant Y82A EndoIII, a protein that binds to DNA but cannot perform DNA-
mediated CT efficiently (22). In previous studies, Y82A did not redistribute in 
mismatched samples (r=0.9 ± 0.1) (22). When XPD is mixed with Y82A 1:1 
(WTXPD/Y82AEndoIII), there is no redistribution onto mismatched strands (r=0.98 ± 0.05). 
WTXPD/Y82AEndoIII matched controls are within error of mismatched results with a 
binding density ratio of 1.11 ± 0.07. The number of proteins bound per kilobasepair 
remains the same between WTXPD/Y82A EndoIII and WTXPD/WTEndoIII mixtures (0.13 
proteins/kbp). When WTXPD is titrated into Y82AEndoIII  at a ratio of 3:1, increasing the 
probability that the enzyme bound to the DNA strand is able to perform CT, the proteins 
once again redistribute onto mismatched strands. 
Complementing WTXPD/WTEndoIII and WTXPD/Y82A EndoIII mixture studies, we 
also investigated signaling between EndoIII and XPD mutant L325V. Similar to EndoIII 
Y82A, XPD L325V cannot redistribute onto mismatched strands. WTXPD/L325VXPD 1:1 
mixtures were examined initially to determine whether L325V, deficient in DNA CT, 
could signal XPD. WTXPD/L325VXPD mixtures showed no redistribution (r=0.88 ± 0.04). 
This result was within error of matched controls, with a binding density ratio revealing 
even a slight preference for short strands (r=0.90 ± 0.05). L325V inhibits XPD from 
relocalizing in the vicinity of lesions, but does L325V have any influence on the search 
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for damage by EndoIII BER protein? WTEndoIII/L325VXPD mixtures were examined and 
exhibited no difference in mismatched versus matched samples, where r=1.02 ± 0.05 and 
0.94 ± 0.04 respectively. As with the WTXPD/Y82AEndoIII mixture, here we see that L325V 
binding alters EndoIII redistribution. Figure 5.5 shows binding density ratio comparisons 
for WTXPD/WTEndoIII, WTXPD/Y82AEndoIII, WTEndoIII/L325VXPD, and WTXPD/L325VXPD  
1:1 protein mixtures.  
For mixtures of active proteins and CT-deficient mutants, we might have expected 
binding density ratios to be equal to that of pure samples of active repair protein.  
However, we are testing redistributions at protein loadings of ~2 per DNA strand.  Thus 
if one of the proteins is CT-defective, there is no protein to which the CT-proficient 
protein may signal. Certainly the striking differences seen between CT-active protein 
mixtures and those containing CT-deficient mutants support the idea that the proteins can 
carry out DNA CT to one another.  Having established that this ability to redistribute in 
the vicinity of mismatches depends on the ability of the protein to carry out DNA CT 
(23), these results thus provide evidence for DNA CT as a means of inter-protein 
signaling. 
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DISCUSSION  
The data presented here indicate that XPD, an archaeal protein from the NER 
pathway, may cooperate with other DNA CT-proficient proteins to localize in the vicinity 
of damage. XPD, a superfamily 2 DNA helicase with 5ʹ′-3ʹ′ polarity, is a component of 
TFIIH that is essential for repair of bulky lesions generated by exogenous sources such as 
UV light and chemical carcinogens (28, 46, 47). XPD contains a conserved [4Fe-4S] 
cluster that has been suggested to be conformationally controlled by ATP binding and 
hydrolysis (25). Mutations in the iron-sulfur domain of XPD can lead to diseases 
including TTD and XP, yet the function of the [4Fe-4S] cluster is currently unknown (23, 
28, 29). Electrochemical studies have shown that when BER proteins MutY and EndoIII 
bind to DNA, their [4Fe-4S] clusters are activated toward one electron oxidation (14, 26). 
XPD exhibits a DNA-bound midpoint potential similar to that of EndoIII and MutY when 
bound to DNA (~80 mV vs. NHE), indicative of a possible role for the [4Fe-4S] cluster 
in DNA-mediated CT (33). For EndoIII, we have determined a direct correlation between 
the ability of proteins to redistribute in the vicinity of mismatches by AFM, and the CT 
proficiency of the proteins measured electrochemically (23). Thus, we may utilize single-
molecule AFM as a tool to probe the redistribution of proteins in the vicinity of base 
lesions and in so doing, the proficiency of the protein to carry out DNA CT.  
 Here, we show that, like the BER protein EndoIII, XPD involved both in 
transcription and NER redistributes in the vicinity of a lesion.  Importantly, this ability to 
relocalize is associated with the ability of XPD to carry out DNA CT, as the L325V 
mutant is DNA CT deficient and does not redistribute effectively onto the mismatched 
strand. 
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These data further provide evidence that two different repair proteins, each 
containing a [4Fe-4S] cluster at similar DNA-bound potential, can communicate with one 
another through DNA-mediated CT. This is especially interesting considering that the 
proteins are from completely different organisms.  However, their critical attributes 
include similar DNA-bound potentials, facilitation of electron exchange, and the ability 
to carry out DNA-mediated CT.   Furthermore, no signaling to effect the redistribution in 
the vicinity of lesions occurs when one partner is CT-deficient. 
Lesion detection by repair proteins depends on the maximum distance over which 
DNA-mediated CT can occur and the percentage of proteins oxidized (6, 22, 48). While 
we have documented that DNA CT occurs over at least 100 bp, we do not yet know the 
maximum distance for this process (5, 49). If CT could proceed only over short distances 
(<500 bp), more than 6 proteins would be required for signaling across strands. Instead, 
only 1-3 proteins are bound to the long matched or mismatched strands in AFM 
experiments, suggesting that DNA CT is occurring over distances much greater than 
those we have measured electrochemically. 
How might this signaling be utilized inside the cell? Surely this ability to 
redistribute in the vicinity of lesions reduces the search process required to find lesions 
across the genome. The higher the concentration of total proteins involved in signaling, 
the more efficient the search process becomes (22). Indeed, XPD may utilize DNA-
mediated CT to signal its presence and perhaps to “call off” other proteins from other 
repair pathways.  Various DNA-binding proteins, such as those involved in repair and 
other DNA transactions, have been found to contain iron-sulfur domains and other redox 
cofactors (50-53). DNA-mediated signaling among DNA-binding proteins that are 
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involved in maintaining the integrity of the genome allows a coordination of repair, 
transcription, and replication processes. 
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Figure 5.2  Atomic force microscopy to visualize protein. Tapping mode AFM images of 
DNA and XPD protein on mica imaged in air. The matched strands and protein (dots) are 
visible on the surface (top). Since the single strand overhangs on the short duplexes have 
been blocked by annealing short oligomers, XPD is bound in random positions on the 
DNA.  Zoomed-in images of DNA long (3.8 kbp) and short (1.6 and 2.2 kbp) strands 
with bound proteins (black arrows) are shown below. Images were acquired with a scan 
size of 2 x 2 µm2 or 3 x 3 µm2, at a rate of 3.05 Hz with a data scale of 10 nm/ 0.5 V.  
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Figure 5.3  Electrochemistry of WT and L325V SaXPD (Left) Cyclic Voltammogram 
(CV) of WT SaXPD [8 µM] (green) and L325V SaXPD [8 µM] (red) on DNA modified 
electrodes after 90 minutes. (Right) Quantitation of XPD and mutant L325V protein 
density ratios (<10% uncertainty) where C:A indicates a mismatch is contained in long 
strands. The unmarked bars show the control measurements for fully matched long and 
short strands.   
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Figure 5.4 Representative tapping mode AFM images. Fully matched long and short 
DNA strands (left) or mismatched long DNA and matched short DNA strands (right) are 
incubated overnight with XPD/EndoIII 1:1 protein mixture. Inset shows zoomed-in view 
of a long DNA strand with both large and small proteins bound.  
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Figure 5.5   Binding density ratio of mixtures in SaXPD and EndoIII.  XPD (red 
text)/EndoIII (blue text) and mutant mixtures binding density ratio comparisons. 
Quantitation of protein density ratios (<10% uncertainty) where C:A indicates a 
mismatch is contained in long strands. WTXPD/WTEndoIII mixtures 1:1 (purple), both 
proteins CT proficient, redistribute onto mismatched strands. WTXPD/Y82AEndoIII  and 
WTEndoIII/L325VXPD  1:1 mixtures (green and orange respectively), Y82A and L325V 
both mutants deficient in CT, do not show redistribution. WTXPD/L325VXPD 1:1 mixtures 
(blue) do not show redistribution, as XPD cannot perform DNA-mediated signaling with 
itself if the L325V mutant is present. 
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a.  Binding Density Ratio (BDR) is reported as (number of proteins bound on 
long strands (3.6 kbp)) /number of long strands) divided by the (number of proteins on 
short strands (1.9 kbp))/number of short strands) normalized for length. (CA) represents 
samples with long mismatched strands. 
b. These data represent three individual samples with 10-20 images per sample. 
L325V is a mutant of wild type XPD, and Y82A is a mutant of wild type EndoIII. 
c. Error is reported as the (total number of proteins divided by the square root of 
the total number of proteins counted) times 100 for each type of sample. 
Table 5.1. Binding Density Ratios for Atomic Force Microscopy Samples 
Sample BDRa,b Long Strands Proteins Short Strands Proteins Error (%)c Prot./Kbp
0.6 uM XPD 0.94 307 216 360 142 5.3 0.19
0.6 uM XPD (CA) 1.54 354 304 323 95 5 0.20
0.3 uM XPD 1.08 304 123 502 99 6.7 0.11
0.3 uM XPD (CA) 1.38 376 271 354 97 5.2 0.18
L325V 0.6 uM 1.05 221 149 251 85 6.5 0.18
L325V 0.6 uM (CA) 1.14 311 236 415 145 5 0.19
XPD/EndoIII 1:1 1.02 221 127 257 76 7 0.15
XPD/EndoIII 1:1 (CA) 1.75 253 150 370 66 7.6 0.13
XPD/Y82A 1:1 1.11 468 183 665 123 6 0.10
XPD/Y82A 1:1 (CA) 0.98 496 258 538 150 5 0.14
EndoIII/L325V 1:1 0.94 327 263 412 186 4.7 0.22
EndoIII/L325V 1:1 (CA) 1.02 361 217 553 171 5.1 0.16
XPD/L325V 1:1 0.90 309 174 408 134 5.7 0.16
XPD/L325V 1:1 (CA) 0.88 564 329 653 227 4.2 0.16
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 As a molecule, DNA appears at first glace to be simple, but is in actuality 
incredibly complicated, and is the basis of cell life.  DNA is composed of only four 
unique sugars, the nucleobases, connected by a sugar phosphate backbone.  Individual 
DNA strands base pair in an anti-parallel manner to form a double helix.  Permutations in 
the sequence of the four individual nucleobases encode the entire genome for a particular 
organism.  Genetic information is subsequently transcribed into RNA that is then 
translated into proteins, which perform the majority of cellular functions.  Therefore, 
mutations in the genome have extremely detrimental downstream effects that can lead to 
many diseases, including progeria and cancers.  DNA damage comes from a variety of 
sources, ranging from external chemicals and ionizing energy to internal reactive oxygen 
species and mistakes by the proteins involved in genome replication.  The cell has 
developed many pathways to prevent and repair DNA damage.  These processes, 
including base excision repair (BER), nucleotide excision repair (NER), homologous 
recombination (HR), non-homologous end joining (NHEJ), and mismatch repair (MMR), 
all involve the coordination of dozens of proteins that must identify a site of DNA 
damage and subsequently coordinate the repair of the lesion.  While some proteins are 
involved in more than one repair pathway, many of them are distinct and are only utilized 
in a single repair pathway.  Throughout many organisms, these repair processes are well 
conserved, with protein homologues identified in each organism.       
 One unique property of DNA that is often overlooked is its ability to conduct 
charge.  As a duplex, DNA is capable of sending electrons through the π-stacked 
aromatic bases in a phenomenon known as DNA Charge Transport (CT).  This process is 
sensitive to the integrity of the DNA π-stack, as perturbations to individual bases 
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diminishes the ability of the molecule to conduct charge, while damage to the sugar 
phosphate backbone will not attenuate CT.  DNA CT has been observed through 100 
bases (34 nm) and is believed to occur over much longer distances.  Additionally, it has a 
β value, which reflects the dependence of electron transfer on distance, less than 0.05 
making it an especially efficient conductor of charge.   It has been proposed that proteins 
can utilize DNA-mediated CT to signal one another to coordinate at a site of DNA 
damage.  Using two base excision repair (BER) proteins from E. coli, EndoIII and MutY 
that contain a [4Fe-4S] cluster, it was found that these proteins both exhibit a DNA bound 
redox potential of 80 mV versus NHE.  We also found that in the oxidized state (3+), 
these proteins have a 1000-fold increase in binding affinity for DNA as compared to the 
reduced state (2+).  A model was therefore developed to describe the coordinated 
signaling between BER proteins to localize to a site of DNA damage.  Briefly, when a 
redox protein binds DNA, it is activated towards oxidation and releases an electron to a 
distally bound protein through the DNA.  If the DNA is intact, the second protein can 
receive the electron, become reduced, and dissociate from the DNA.  However, if the 
DNA is damaged, this process cannot occur; the protein remains bound on the DNA and 
subsequently processes toward the site of damage.  This model describes an efficient 
search process for proteins that are low in copy number with a very short search time for 
scanning the entire genome.  It is therefore important to examine the role of proteins that 
a) contain a redox active cluster, b) bind DNA, and c) have an active role in DNA repair.  
This work expands on our collection of DNA binding proteins that can utilize DNA-
mediated CT and furthers our understanding of the role of DNA-mediated signaling 
between repair proteins as a conserved mechanism throughout many organisms. 
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 We electrochemically characterized the NER helicase XPD from the thermophile 
Sulfolobus acidocaldarius.  Using a DNA-modified electrode with a 5ʹ′ ssDNA overhang, 
which is a substrate for the helicase, we observed a DNA-bound redox potential of 82 
mV versus NHE, consistent with the previously reported value for BER proteins.  We 
then sought to understand what role ATP hydrolysis has on DNA-mediated signaling, as 
XPD is an ATP-dependent helicase.  After incubating SaXPD on the electrode, a titration 
of ATP and ATP-γ-S was performed.  When 5 mM ATP was added, an increase in the 
current was observed, consistent with previously reported kinetic measurements.   A 
mutant deficient in helicase and ATPase activity, G34R, was subjected to the same 
conditions, and, upon ATP addition, showed minimal increase in electrochemical current.   
SaXPD exhibits a preference for a 5ʹ′ ssDNA overhang, and when this ATPase assay was 
performed with either a 3ʹ′ ssDNA overhang or no overhang, only a minimal increase in 
signal was observed, followed by subsequent signal decay, suggesting that the protein is 
sliding off the DNA substrate.  Therefore, SaXPD exhibits a DNA-mediated signaling 
event associated with ATP hydrolysis.  The ATP binding site is over 30 angstroms from 
the cluster, and it is intriguing that ATP binding and hydrolysis can affect DNA mediated 
signaling.   The current increase was small, approximately 10%, likely because the 
protein functions at elevated temperature, and these assays are performed at room 
temperature.   
 Because of the results observed with SaXPD, we were then interested in exploring 
the effect of disease-related mutants on DNA-mediated electrochemistry; databases of 
protein mutants involved in the XP-related diseases xeroderman pigmentosum (XP), 
trichothiodystrophy (TTD), and cockayne syndrome (CS) were used to identify targets.  
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The G34R mutant is a typical mutant because it lacks ATPase and helicase activity, but 
other mutants involved in disease are not as straightforward.  In Chapter 3, we describe 
the electrochemistry of the disease-related K84H, L325V, R460P, R460W, A511R, and 
the artificial Y104A mutants.  The L325V, R460P, R460W, and A511R all appear to 
have reduced DNA-mediated signaling relative to the WT proteins, while the Y104A and 
K84H mutants have enhanced electronic signaling.  The CT-deficient mutants L325V and 
R460W, which maintain ATPase activity, helicase activity, bind DNA, and bind TFIIH, 
were particularly puzzling because they continued to lead to either TTD, XP, or COFS.  
Perhaps their deficiencies in CT are the major contributing factor to the disease state.  
Attempts were made to restore CT using our enhanced Y104A mutant in combination 
with either CT-deficient mutant, but each double mutant exhibited lower electrochemical 
signals than its single mutant counterparts.  Using the SaXPD crystal structure, we 
modeled a mutant to restore CT to the L325V mutant.  This L325V/M331A mutant has 
an electrochemical signal slightly higher than the original L325V mutant, but lacks 
ATPase and helicase activity.      
We then focused on the yeast S. cerevisiae XPD homologue, Rad3.  A haploid 
deletion strain of Rad3 was generated and complemented with a plasmid-based copy of 
Rad3, enabling ready manipulation of the Rad3 copy in the cell.  The analogous 
mutations to the SaXPD mutants were generated and assayed for survival.  All mutants 
were viable, indicating that none completely abolish Rad3 activity in vivo.  The viability 
of these disease-related mutants speaks to the differences between the ScRad3 and human 
XPD.  To test the ability of Rad3 mutations in vivo, a UV-induced and NQO-induced 
survival assay was performed.  Both of these assays yielded similar results, indicating 
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that UV-induced lesions and quinol-DNA adducts are repaired with the same efficiency 
by ScRad3.  The ATPase and helicase deficient ScRad3 mutants G47R, R618P, and 
C665R showed little to no growth at either 20 J/m2 or 20 ng/mL NQO, while the I463V/Δ 
and R618W mutants showed growth similar to the WT strain, albeit with a slight 
deficiency.  When monitoring key genes involved in DNA repair, no strain-specific 
increase in transcription was observed, indicating that Rad3 is not involved in regulating 
these genes in response to DNA damage.  
In the ScRad3 strain, when mutations were made at the R618 position, we found 
survival in the order of proline < glutamate < alanine < tryptophan < tyrosine ≈ leucine ≈ 
arginine (WT), suggesting that mutations at this position drastically affect survival.  
Large bulky mutations that affect structure, such as proline and glutamate, lead to 
inviability, while maintaining aromaticity in tryptophan and tyrsone lead to results similar 
to the WT Rad3 strain.  To investigate the kinetics of the repair process, growth was 
monitored and demonstrated that the G47R, R618P, and C665R mutant strains show 
significant attenuation in growth in the presence of NQO, while the WT, I463V/Δ, and 
R618W strains grow with only a small shift in t1/2 ≈ 1.5 hours.   
Finally, the ability of Rad3 to repair other DNA damage products was tested 
through monitoring of the growth of WT and G47R Rad3 strains in the presence of 
methyl methanesulfonate (MMS), camptothecin (CPT), and hydroxyurea (HU).  For HU, 
both strains exhibited similar attenuated growth, while the G47R strain showed 
significant attenuation relative to the WT strain in the presence of MMS and CPT, 
suggesting that Rad3 assists with the repair of methylated DNA or cross-linked DNA, 
respectively.  To better understand the biochemistry of the protein, we purified Rad3 
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from S. cerevisiae in E. coli cells.  Mutants purified from E. coli exhibited ATPase, 
helicase, and DNA binding activities, albeit with variation from previously reported 
SaXPD results, likely due to protein instability in the storage buffer.  Rad3 also contains 
a [4Fe-4S] cluster, as observed by UV-visible spectroscopy.  When incubated on a DNA-
modified electrode, Rad3 exhibits a DNA-bound redox potential of 80 mV versus NHE.  
All mutants exhibit this potential and have the same current intensity relative to the WT 
protein.  While many of the disease-related mutants show diminished activities in our in 
vivo S. cerevisiae assay, the R618W and I463V/Δ mutants are viable.  The ScRad3 
protein is significantly different from the previously studied SaXPD, and a full 
understanding of ScRad3 will establish what role CT plays and provide key insights into 
the molecular basis for XP-related diseases. 
 The fact that these proteins all have a similar potential on a DNA-modified 
electrode enables the expansion of our model for protein utilization of DNA-mediated 
signaling.  We have developed an atomic force microscopy (AFM) assay to measure 
distribution onto well-matched and mismatched DNA strands.  In this assay, the BER 
protein EndoIII redistributes onto a long strand of DNA containing a C:A mismatch, 
compared to a short strand that is well-matched.  Similarly, with SaXPD, the protein 
redistributes with a binding density ratio (BDR) of 1.54 ± 0.08, and the L325V CT 
deficient mutant redistributes with a BDR of 1.14 ± 0.06.  When a mixture of the WT and 
L325V mutant SaXPD were incubated with DNA, a BDR of 0.88 ± 0.04 was found, 
suggesting that a deficiency in protein CT does not allow proteins to redistribute near a 
DNA lesion.  When SaXPD and E. coli EndoIII were mixed, a BDR of 1.75 ± 0.14 was 
observed.  When a CT deficient version of SaXPD or EndoIII was added, BDRs of 1.02 ± 
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0.05 and 0.98 ± 0.05 were observed, respectively.  These data suggest that the CT 
proficiency in a protein affects redistribution near the site of a DNA lesion that attenuates 
CT.  These two proteins are also from both entirely different repair pathways (NER 
versus BER) and completely different organisms (S. acidocaldarius versus E. coli), 
suggesting that DNA-mediated signaling is a general mechanism amongst all forms of 
life. 
 Taken together, this body of work vastly expands our repertoire of proteins that 
are capable of utilizing DNA CT.  We have correlated ATPase activity with 
electrochemical signaling, as observed in SaXPD, and demonstrated that signaling 
between proteins from different organisms can localize at a DNA lesion.  We have begun 
work to uncover other proteins that can utilize this signaling pathway.  Beyond the NER 
SaXPD and ScRad3 proteins and the BER EndoIII and MutY proteins, the human 
primase, yeast Dna2, E. coli DinG, and the yeast polymerases all contain a redox active 
[4Fe-4S] cluster.  All of these proteins exhibit the same DNA-bound redox potential, 
allowing them to signal one another.  Perhaps to coordinate repair between the different 
repair pathways, these proteins utilize DNA-mediated signaling to identify the presence 
of other redox active proteins or to simply be used as redox shuttles to coordinate the 
repair proteins in the vicinity of DNA lesions.   
 
 
Appendix 1 
 
 
 
 
 
 
 
 
 
Primers and strains used in S. cerevisiae in vivo assays 
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TPM 033: CTTCCGTTATTATCACTTCAGGGACCGTATCACCATTAG  (39-mer) 
TPM 034: CTTGGATACATGTCTAATGGTGATACGGTCCCTGAAG   (37-mer) 
TPM 046: GATGCCTTCAGGAACACGTAAAACGG    (26-mer) 
TPM 041: GGATAGTAATGAGACCGTTTTACGTGTTCCTG  (32-mer) 
TPM 042: TATCGATTTTGATCATCAATATCCCAGAACTGTGC  (35-mer) 
TPM 043: TACCTATCATCAGCACAGTTCTGGGATATTG  (31-mer) 
TPM 044: ACATGCAGCTCAACGTCTGGGG    (22-mer) 
TPM 045: AGTACTCTCCCCAGACGTTGAGCTG    (25-mer) 
TPM 048: CAGTTTTAAAGTTTAACATTCTTGGATACGCGTCTAATGGTG  (42-
mer) 
TPM 049: CAGGGACCGTATCACCATTAGACGCGTATCCAAG    (34-
mer) 
TPM 057: CTTCCGTTATTATCACTTCAGGGACCCTATCACCATTAG  (39-mer) 
TPM 058: CTTGGATACATGTCTAATGGTGATAGGGTCCCTGAAG   (37-mer) 
TPM 059: CTTCCGTTATTATCACTTCAGGGACCTTCTCACCATTAG  (39-mer) 
TPM 060: CTTGGATACATGTCTAATGGTGAGAAGGTCCCTGAAG   (37-mer) 
TPM 071: GATTTTGATCATCAATATGGCCCAACTGTGCTGA  (34-mer) 
TPM 072: TACCTATCATCAGCACAGTTGGGCCATATTG   (31-mer) 
TPM 073: GATTTTGATCATCAATATGGCTGGACTGTGCTGA  (34-mer) 
TPM 074: TACCTATCATCAGCACAGTCCAGCCATATTG  (31-mer) 
TPM 099:  ACTGACATGGCCATATCCAATGACCAAGAGGGTGTATCT (39-mer) 
TPM 100: AACAGATACACCCTCTTGGTCATTGGATATGGCCATGTC (39-mer) 
TPM 102: GATTTTGATCATCAATATGGCGCAACTGTGCTGA  (34-mer) 
TPM 103: TACCTATCATCAGCACAGTTGCGCCATATTG   (31-mer) 
TPM 104: GATTTTGATCATCAATATGGCGAAACTGTGCTGA  (34-mer) 
TPM 105: TACCTATCATCAGCACAGTTTCGCCATATTG  (31-mer) 
TPM 106: GATTTTGATCATCAATATGGCCTAACTGTGCTGA  (34-mer) 
TPM 107: TACCTATCATCAGCACAGTTAGGCCATATTG   (31-mer) 
TPM 112: CGATTTTGATCATCAATATGGCTACACTGTGCTGATG  (37-mer) 
TPM 113: GGATACCTATCATCAGCACAGTGTAGCCATATTGAT  (36-mer) 
 
TPM 033:  Forward Primer to I463V mutation in Rad3  
TPM 034:  Reverse Primer to I463V mutation in Rad3  
TPM 046:  Forward Primer to make G47R in Rad3 
TPM 041:  Reverse Primer to make G47R in Rad3 
TPM 042:  Forward Primer to make R460P (G617P) 
TPM 043:  Reverse Primer to make R460P (G617P) 
TPM 044:  Forward Primer to make A511R (C665R) 
TPM 045:  Reverse Primer to make A511R (C665R) 
TPM 047:  Reverse Primer to mutate M488A 
TPM 048:  Forward Primer to mutate I463V/M488A  
TPM 057:  Forward Primer to I460L mutation in Rad3 
TPM 058:  Reverse Primer to I460L mutation in Rad3 
TPM 059:  Forward Primer to I460F mutation in Rad3 
TPM 060:  Reverse Primer to I460F mutation in Rad3 
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TPM 071:  Forward Primer to R460P (R618P) Mutation in Rad3 
TPM 072:  Reverse Primer to R460P (R618P) Mutation in Rad3 
TPM 073:  Forward Primer to R460W (R618W) Mutation in Rad3 
TPM 074:  Reverse Primer to R460W (R618W) Mutation in Rad3 
TPM 099:  Forward Primer for 716-730 del in Rad3 
TPM 100:  Reverse Primer for 716-370 del in Rad3   
TPM 102:  Forward Primer to R460A (R618A) Mutation in Rad3  
TPM 103:  Reverse Primer to R460A (R618A) Mutation in Rad3 
TPM 104:  Forward Primer to R460E (R618E) Mutation in Rad3  
TPM 105:  Reverse Primer to R460E (R618E) Mutation in Rad3 
TPM 106:  Forward Primer to R460L (R618L) Mutation in Rad3 
TPM 107:  Reverse Primer to R460L (R618L) Mutation in Rad3 
TPM 112:  Forward Primer to R460Y (R618Y) Mutation in Rad3  
TPM 113:  Reverse Primer to R460Y (R618Y) Mutation in Rad3 
 
 
Table S1.1.  Primers used for Site Directed Mutagenesis (SDM).  Sequence are shown 
above with description as indicated below. 
 
TPM 061: ATTATATGTTTAGAGGTTGCTGCTTTGG    (28-mer) 
TPM 062: CAATTCGTTGTAGAAGGTATGATGCC    (26-mer) 
TPM 063: CACGGATAGTGGCTTTGGTGAACAATTAC   (29-mer) 
TPM 064: TATGATTATCTGGCAGCAGGAAAGAACTTGGG   (32-mer) 
TPM 065: GCTGGCACTCATATCTTATCGTTTCACAATGG   (32-mer) 
TPM 066: GAACCTGCTGTCAATACCGCCTGGAG    (26-mer) 
TPM 067: ATTTGCCCGTCGTGTTTTGCTGTG    (24-mer) 
TPM 068: TATGCTGAATCTCGTCTCTAGTTCTGTAGG   (30-mer) 
TPM 069: AGTTCAAGGTCTCCATTCTGC   (21-mer) 
TPM 070: CTCGGCTCTTCGTATATTTCCC   (22-mer) 
TPM 075: AAATGTTTGGTAATGGGCGTG    (21-mer) 
TPM 076: TTGCATGACGGAGACTGATG    (20-mer) 
TPM 077: GCTACACCAACATCCATTAACG    (22-mer) 
TPM 078: CCAGTATTAGAGAACCACGACAG    (23-mer) 
TPM 079: ATAACGGGTGGATTCTTGGAC    (21-mer) 
TPM 080: CCCGTCCTCAGCATTACTATC    (21-mer) 
TPM 081: AGCATACTCCAAGCCAATCG    (20-mer) 
TPM 082: CCGTAGTGTCCTTCAGAGTTTC    (22-mer) 
TPM 083: TCAGGGCATACGGTCTTTTG   (20-mer) 
TPM 084: CTGTTGGGCGGTAGATCAC   (19-mer) 
TPM 085: CAGATAGTCAACGTCCAGGTAAG    (23-mer) 
TPM 086: AGATTTGATGGTCTCACGCG    (20-mer) 
TPM 087: TTACGCCAGTTTCCCCTAAC    (20-mer) 
TPM 088: TTGGAAGCCCTCTCAGAAATAG    (22-mer) 
TPM 089: AGAGCATTCTATAAGGGCACAC    (22-mer) 
TPM 090: TTGTATCTCATGACACCCGTG    (21-mer) 
TPM 091: GTCCTCATACTGCTCTCACATG    (22-mer) 
TPM 092: GCATACGGCGTCATTAATTCG    (21-mer) 
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TPM 093: GAGTGTGCTGGTAGGATTGG   (20-mer) 
TPM 094: ATGGGTGAGCATGTATTCAGAG  (22-mer) 
TPM 095: ATGGATCAACCTGTCGACTTG  (21-mer) 
TPM 096: TGTAGGAACCCACTCTTCAAATC  (23-mer) 
TPM 097: ACCATATGAAGGCTCTGTTGAG  (22-mer) 
TPM 098: TCACGCGAATGATATCACCC   (20-mer) 
 
TPM 061:  Forward Primer ACT1 RT-QPCR Tm 64.2 
TPM 062:  Reverse Primer ACT1 RT-QPCR Tm 63.8 
TPM 063:  Forward Primer ALG9 RT-QPCR Tm 67.3 
TPM 064:  Reverse Primer ALG9 RT-QPCR Tm 69.2 
TPM 065:  Forward Primer TFCI RT-QPCR Tm 68.5 
TPM 066:  Reverse Primer TFCI RT-QPCR Tm 69.6 
TPM 067:  Forward Primer PDAI RT-QPCR Tm 68.3 
TPM 068:  Reverse Primer PDAI RT-QPCR Tm 66.3 
TPM 069:  Forward Primer Rad3 RT-QPCR Tm 62.0 
TPM 070:  Reverse Primer Rad3 RT-QPCR Tm 62.2 
TPM 075:  Forward Primer Ssl2 RT-QPCR Tm 62.0 (143) 
TPM 076:  Reverse Primer Ssl2 RT-QPCR Tm 62.1 
TPM 077:  Forward Primer Rad1 RT-QPCR Tm 61.5 (125) 
TPM 078:  Reverse Primer Rad1 RT-QPCR Tm 61.9 
TPM 079:  Forward Primer Rad2 RT-QPCR Tm 62.0 (122) 
TPM 080:  Reverse Primer Rad2 RT-QPCR Tm 61.6 
TPM 081:  Forward Primer Met18 RT-QPCR Tm 62.3 (126) 
TPM 082:  Reverse Primer Met18 RT-QPCR Tm 62.1 
TPM 083:  Forward Primer Rad50 RT-QPCR Tm 62.1 (150) 
TPM 084:  Reverse Primer Rad50 RT-QPCR Tm 62.0 
TPM 085:  Forward Primer Isa1 RT-QPCR Tm 61.9 (128) 
TPM 086:  Reverse Primer Isa1 RT-QPCR Tm 62.4 
TPM 087:  Forward Primer Isa2 RT-QPCR Tm 61.8 (146) 
TPM 088:  Reverse Primer Isa2 RT-QPCR Tm 61.7 
TPM 089:  Forward Primer Pol1 RT-QPCR Tm 62.1 (147) 
TPM 090:  Reverse Primer Pol1 RT-QPCR Tm 61.8 
TPM 091:  Forward Primer Pol2 RT-QPCR Tm 62.0 (150) 
TPM 092:  Reverse Primer Pol2 RT-QPCR Tm 61.7 
TPM 093:  Forward Primer Pol3 RT-QPCR Tm 62.0 (137) 
TPM 094:  Reverse Primer Pol3 RT-QPCR Tm 62.1 
TPM 095:  Forward Primer Pol30 RT-QPCR Tm 62.1 (146) 
TPM 096:  Reverse Primer Pol30 RT-QPCR Tm 62.2 
TPM 097:  Forward Primer Rfc1 RT-QPCR Tm 62.0 (84) 
TPM 098:  Reverse Primer Rfc1 RT-QPCR Tm 61.9 
 
Table S1.2. Primers used for qPCR.  Sequences of primers used for the genes involved in 
the qPCR experiments.  
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Parental 
Plasmid 
Rad3 
Mutation 
Strain Transformed 
12AB-Rad3 WT S. cerevisiae  
12AC-Rad3 WT S. cerevisiae 
7AB-HSSG-
12xHis Rad3 
WT E. coli BL21 DE3 pLysS 
7AB-12xHis 
Rad3 
WT E. coli BL21 DE3 pLysS 
7AB-6xHis 
Rad3 
WT E. coli BL21 DE3 pLysS 
7AC-MBP-
6xHis Rad3 
WT E. coli BL21 DE3 pLysS 
 I463V/del71
6-730 
E. coli BL21 DE3 pLysS 
 G47R E. coli BL21 DE3 pLysS 
 R618P E. coli BL21 DE3 pLysS 
 R618W E. coli BL21 DE3 pLysS 
 I463V/M46
8A/del716-
730 
E. coli BL21 DE3 pLysS 
 C665R E. coli BL21 DE3 pLysS 
 I463L E. coli BL21 DE3 pLysS 
PRS314 – Rad3 WT Untransformed 
PRS313 – Rad3 WT S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 I463V/del71
6-730 
S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 G47R S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 R618P S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 R618W S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 I463V/M48
A/del716-
730 
S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 C665R S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 R618A S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 R618E S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 R618L S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
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ΔRad3::kan 
 R618Y S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 G617P S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 I463F S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
 I463L S. cerevisiae his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
ΔRad3::kan 
PRS316 – Rad3 WT S. cerevisiae Mata/Mat α his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0 ΔRad3::kan 
Table S1.3  Table of plasmids and yeast strains developed to study survival of Rad3 
mutations and overexpression of Rad3 in E. coli.  
 
